<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40410286</article-id><article-id pub-id-type="pmc">PMC12102166</article-id>
<article-id pub-id-type="publisher-id">1912</article-id><article-id pub-id-type="doi">10.1038/s41598-025-01912-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Small intestinal neuroendocrine tumors lack early genomic drivers, acquire DNA repair defects and harbor hallmarks of low <italic>REST</italic> expression</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Bolduan</surname><given-names>Felix</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>M&#x000fc;ller-B&#x000f6;tticher</surname><given-names>Niklas</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Debnath</surname><given-names>Olivia</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Eichhorn</surname><given-names>Ines</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Giesecke</surname><given-names>Yvonne</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wetzel</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sahay</surname><given-names>Shashwat</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Zemojtel</surname><given-names>Tomasz</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Jaeger</surname><given-names>Marten</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ungethuem</surname><given-names>Ute</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Roderburg</surname><given-names>Christoph</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Kunze</surname><given-names>Catarina Alisa</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Lehmann</surname><given-names>Annika</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Horst</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Tacke</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Eils</surname><given-names>Roland</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Wiedenmann</surname><given-names>Bertram</given-names></name><address><email>bertram.wiedenmann@charite.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Sigal</surname><given-names>Michael</given-names></name><address><email>michael.sigal@charite.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8426-901X</contrib-id><name><surname>Ishaque</surname><given-names>Naveed</given-names></name><address><email>naveed.ishaque@bih-charite.de</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/001w7jn25</institution-id><institution-id institution-id-type="GRID">grid.6363.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2218 4662</institution-id><institution>Department of Hepatology &#x00026; Gastroenterology, </institution><institution>Charit&#x000e9; Universit&#x000e4;tsmedizin Berlin, </institution></institution-wrap>Campus Virchow-Klinikum and Campus Charit&#x000e9; Mitte, 13353 Berlin, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0493xsw21</institution-id><institution-id institution-id-type="GRID">grid.484013.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 6879 971X</institution-id><institution>BIH Charit&#x000e9; Junior Digital Clinician Scientist Program, </institution><institution>Berlin Institute of Health at Charit&#x000e9; &#x02013; Universit&#x000e4;tsmedizin Berlin, BIH Biomedical Innovation Academy, </institution></institution-wrap>Charit&#x000e9;platz 1, 10117 Berlin, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0493xsw21</institution-id><institution-id institution-id-type="GRID">grid.484013.a</institution-id><institution>Center of Digital Health, </institution><institution>Berlin Institute of Health at Charit&#x000e9; Universit&#x000e4;tsmedizin Berlin, </institution></institution-wrap>Charit&#x000e9;platz 1, 10117 Berlin, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/046ak2485</institution-id><institution-id institution-id-type="GRID">grid.14095.39</institution-id><institution-id institution-id-type="ISNI">0000 0001 2185 5786</institution-id><institution>Department of Mathematics and Computer Science, </institution><institution>Freie Universit&#x000e4;t Berlin, </institution></institution-wrap>Arnimallee 14, 14195 Berlin, Germany </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0493xsw21</institution-id><institution-id institution-id-type="GRID">grid.484013.a</institution-id><institution>Core Facility Genomics, </institution><institution>Berlin Institute of Health at Charit&#x000e9; - Universit&#x000e4;tsmedizin Berlin, </institution></institution-wrap>Charit&#x000e9;platz 1, 10117 Berlin, Germany </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/024z2rq82</institution-id><institution-id institution-id-type="GRID">grid.411327.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2176 9917</institution-id><institution>Department of Gastroenterology, Hepatology and Infectious Diseases, </institution><institution>University Hospital D&#x000fc;sseldorf, Medical Faculty of Heinrich Heine University D&#x000fc;sseldorf, </institution></institution-wrap>D&#x000fc;sseldorf, Germany </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/001w7jn25</institution-id><institution-id institution-id-type="GRID">grid.6363.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2218 4662</institution-id><institution>Institute of Pathology, </institution><institution>Charit&#x000e9; - Universit&#x000e4;tsmedizin Berlin, Corporate Member of Freie Universit&#x000e4;t Berlin and Humboldt Universit&#x000e4;t zu Berlin, </institution></institution-wrap>10117 Berlin, Germany </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02pqn3g31</institution-id><institution-id institution-id-type="ISNI">0000 0004 7865 6683</institution-id><institution>German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), </institution></institution-wrap>Berlin, Germany </aff><aff id="Aff9"><label>9</label>Berlin Institute for Medical Systems Biology, Hannoversche Stra&#x000df;e 28, 10115 Berlin, Germany </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><elocation-id>17969</elocation-id><history><date date-type="received"><day>8</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>9</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The tumorigenesis of small intestinal neuroendocrine tumors (siNETs) is not understood and comprehensive genomic and transcriptomic data sets are limited. Therefore, we performed whole genome and transcriptome analysis of 39 well differentiated siNET samples. Our genomic data revealed a lack of recurrent driver mutations and demonstrated that multifocal siNETs from individual patients can arise genetically independently. We detected germline mutations in Fanconi anemia DNA repair pathway (FANC) genes, involved in homologous recombination (HR) DNA repair, in 9% of patients and found mutational signatures of defective HR DNA repair in late-stage tumor evolution. Furthermore, transcriptomic analysis revealed low expression of the transcriptional repressor REST. Summarizing, we identify a novel common transcriptomic signature of siNETs and demonstrate that genomic alterations alone do not explain initial tumor formation, while impaired DNA repair likely contributes to tumor evolution and represents a potential pharmaceutical target in a subset of patients.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Computational biology and bioinformatics</kwd><kwd>Cancer genomics</kwd><kwd>Cancer</kwd><kwd>Gastrointestinal cancer</kwd></kwd-group><funding-group><award-group><funding-source><institution>Charit&#x000e9; - Universit&#x000e4;tsmedizin Berlin (3093)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Small intestinal neuroendocrine tumors (siNETs) are the most frequent form of small bowel cancer, overall slow-growing, well-differentiated and often diagnosed in a metastatic state, precluding curative treatment options. In such a palliative setting, systemic treatment is needed, however, the number of available therapeutic options is limited<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. For the development of novel precision treatment options, robust knowledge of the tumor biology is mandatory. As cancer is in general a disease of the genome<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, its alterations are key features to understand the tumor biology. Previous studies have investigated and described the genomic alterations of siNETs<sup><xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref></sup>.</p><p id="Par3">First, siNETs exhibit a broad range of chromosomal amplifications and deletions including the loss of chromosome 18 and amplifications of chromosomes 4, 5, 14, and 20, but so far, their tumorigenic function remains unidentified<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. In a single study, amplifications in genes of the PI3K/AKT/mTOR signaling pathway were described in 14 out of 48 siNETs (29%) explaining the partial response of mTOR inhibitors in siNET treatment<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>.</p><p id="Par4">Furthermore, siNETs are in general mutationally quiet and microsatellite stable<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. <italic>CDKN1B</italic> mutations have been considered as potential drivers in siNET development<sup><xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. <italic>CDKN1B</italic> encodes for p27 and germline mutations are associated with the multiple endocrine neoplasia (MEN) syndrome MEN4<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. Nonetheless, given the relatively low frequency of <italic>CDKN1B</italic> alterations (8%<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, 8.5%<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, 11%<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, 13%<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> and 23%<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> of siNET samples), its general role as a recurrent driver of siNET tumorigenesis is not clear. Additionally, alterations in the <italic>TNRC6B</italic> and <italic>CDKN2A</italic> genes as possible tumor suppressors were observed in a small subset of siNETs<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. Recently, a whole genome sequencing study of siNETs revealed driver mutations like <italic>TP53</italic>, <italic>RB1</italic>, <italic>KRAS</italic>, <italic>NRAS</italic>, and <italic>MET</italic> mutations<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. However, this study included also G3 tumors which display a different biology and therefore genetic profile than G1/G2 siNETs.</p><p id="Par5">The transcriptome of siNETs has not been extensively studied, and only a limited amount of data exists<sup><xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref></sup>. These studies elucidated different expression profiles within siNETs<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup> or between primary tumor and metastases<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>. With one exception, a combined analysis of genomic and transcriptomic alterations has not been performed yet. Only Postel et al<italic>.</italic> studied the genome and transcriptome of five siNET paired samples consisting of liver metastases and primary tumors<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. They identified several differentially expressed genes and pathways between primary tumor and metastasis but without modelling the differential sampling sites or tumor cell content of samples, and so far without further implications.</p><p id="Par6">Here, we provide the largest study of a combined genome and transcriptome analyses of siNETs. We performed whole genome and bulk RNA sequencing of 39 siNET samples derived from 32 patients of our NET clinical center. Consistent with previous results, we detected chromosomal aberrations like deletion of chromosome 18. We observed no strong common driver mutations and by analyzing paired tumor samples found that multifocal tumors are genetically independent<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup> thus we conclude that no somatic genomic event causes initial siNET formation. While we observed mutational signatures of defective DNA repair in the majority of samples, these were traced to later in evolution, therefore not sufficient to be considered as early driver events. Furthermore, we identified germline predisposition mutations of Fanconi anemia genes, which are involved in DNA repair, in 9% of our patients. These data together suggest that tumor formation of siNETs is not driven by somatic genomic events alone, but impaired DNA repair likely contributes to diseases progression and provides arguments for targeting defective homologous recombination in a subset of patients. To characterize the result of a yet unknown tumor initiating event, we performed RNA sequencing and revealed a novel transcriptomic signature of siNETs defined by low expression of the transcription repressor REST. Our data provide novel molecular insights into pathogenesis of siNETs and may be useful for identifying patients at risk for advanced siNET formation.</p></sec><sec id="Sec2"><title>Results</title><sec id="Sec3"><title>Mutational signatures implicate low mutational burden in siNETs</title><p id="Par7">First, we established a cohort of clinically well characterized samples from 32 siNET patients from which neoplastic and adjacent healthy tissue was obtained (Supplementary Table <xref rid="MOESM2" ref-type="media">1</xref>). In total we profiled 39 samples, of which there were 22 siNET primary tumors (median Ki67 2%), 12 hepatic metastases of siNETs (median Ki67 5%), 4 lymph node metastases and 1 peritoneal metastasis. All samples were reviewed by pathologists and classified as neuroendocrine tumors G1/G2.</p><p id="Par8">DNA and RNA were isolated from the tumor and normal samples and subjected to library preparation and short read sequencing-by-synthesis. DNA sequencing yielded high quality data (Fig. <xref rid="MOESM1" ref-type="media">S1</xref>a, Supplementary Table <xref rid="MOESM3" ref-type="media">2</xref>) with an average genome coverage of 85&#x02009;&#x000d7;&#x02009;in tumors and 51&#x02009;&#x000d7;&#x02009;in matched controls and an average of 308 million RNA-seq read pairs (Supplementary Table <xref rid="MOESM4" ref-type="media">3</xref>), followed by identification of somatic mutations. Comparable to other studies of siNETs we observed a low number of somatic mutations<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>, which also corresponded to a low tumor mutational burden (mean&#x02009;&#x000b1;&#x02009;sem: 0.98&#x02009;&#x000b1;&#x02009;0.06, median: 0.88 mutations per Mb coding sequence, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a).</p><p>
<fig id="Fig1"><label>Fig. 1</label><caption><p>Mutational landscape of siNETs. (<bold>a</bold>) Tumor mutational burden (TMB) of each sample as somatic SNVs and InDels in coding regions divided over the summed lengths of distinct non-overlapping coding regions. (<bold>b</bold>&#x02013;<bold>d</bold>) COSMIC mutational signatures for (<bold>b</bold>) single nucleotide variations (SNVs), (<bold>c</bold>) indels, and (<bold>d</bold>) copy number aberrations (CNAs). (<bold>e</bold>, <bold>f</bold>) CNA landscape in siNETs of (<bold>e</bold>) primary tumors and (<bold>f</bold>) metastasis. CDKN1B location is highlighted. (<bold>g</bold>) Recurrently mutated genes (3 or more patients) in siNETs and CDKN1B mutations. <italic>P</italic> primary tumor, <italic>MH</italic> hepatic metastasis, <italic>MN</italic> lymph node metastasis, <italic>MP</italic> peritoneal metastasis.</p></caption><graphic xlink:href="41598_2025_1912_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par9">When analyzing the COSMIC single base substitution (SBS) mutational signatures<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> we mainly detected SBS5 (unknown aetiology/clock-like), SBS3 (defective homologous recombination DNA repair), SBS40 (unknown aetiology/age-related), SBS1 (spontaneous deamination 5-methylcytosine to thymine/clock-like) and to a very little extent SBS13 (APOBEC activity) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). This is in line with previous SBS mutational signature analyses of siNETs<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> and shows the relatively mutationally quiet nature of siNETs with aging related signatures being the most prominent. The presence of SBS signature 3 may indicate a role for defective HR DNA repair in siNET tumorigenesis or progression.</p><p id="Par10">Similar to the low SNV burden in our samples, we also observed a low number of indels (mean&#x02009;&#x000b1;&#x02009;sem: 183&#x02009;&#x000b1;&#x02009;11, median: 176, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c). We investigated COSMIC indel (ID) mutational signatures<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> in our samples. The most prominent signature was ID12, which is defined by deletions of 2 base pairs&#x000a0;(bp) in&#x02009;&#x02265;&#x02009;6&#x000a0;bp number repeat units. The aetiology of ID12 is unknown, and it was observed to a little extent in prostate adenocarcinoma but not in endocrine pancreatic tumors<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Signatures ID1 (aetiology: slippage during DNA replication of the replicated DNA strand), ID2 (aetiology: slippage during DNA replication of the template DNA strand), ID3 (tobacco smoking), ID5 (unknown aetiology) and ID9 (unknown aetiology) were also found in our cohort but with a very low extent when compared to other tumor entities<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>.</p><p id="Par11">Recently, signatures of copy number alteration (CNAs) in human cancer were published<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Although these signatures were originally derived from SNP array data, we analyzed our WGS data for these CNA signatures (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>d). Again, we detected a relatively low mutational exposure, with the diploid signature 1 being most prominent. In metastases the portion of the tetraploid CNA signature 2 was higher. In four samples we detected signature 9, a signature of chromosomal instability. Further analyses could demonstrate that in two of these tumors chromothripsis occurred (P16 and P20). Chromothripsis as a chromosomal catastrophe with chromosomal shattering and rearrangement was previously described in siNETs on chromosome 12 and 13<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. Interestingly, it also occurred in one of our samples on chromosome 13 (P16). The other sample (P20) displayed chromothripsis on the p-arm of chromosome 9. Additionally, we detected signature 21 with unknown aetiology. This signature 21 was found in 5 samples and was previously exclusively described in pheochromocytoma and paraganglioma, both neuroendocrine tumor entities. Although the proportion of this signature is quite low, it only seems to appear in neuroendocrine tumor entities and may be specific for them. Further understanding of the aetiology of CNA signature 21 could provide new insights in the tumorigenesis and/or tumor propagation of these neoplasms.</p></sec><sec id="Sec4"><title>Chromosomal aberrations of siNETs are enriched in metastasis</title><p id="Par12">We further investigated the CNAs in our siNET cohort (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>e,f). We detected gains on chromosome 4, 5, 7, 10, 14, 17 and 20 and losses on chromosome 6, 9, 11, 13, 16 and 18, which is in line with previous reports<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. Chromosomal aberration, especially gains, are more frequent in metastases, which is consistent with a higher amount of the tetraploid CNA signature 2 in metastases described earlier, indicating that chromosomal aberrations accumulate over time. Interestingly, only chromosome 18 deletions were observed less frequently in metastatic (50%) tumors compared to primaries (68%), suggesting that chromosome 18 deletion is not necessary for the evolution of metastases but gives an advantage on primary site. In accordance with this postulation, one of our patients (P1) displayed loss of chromosome 18 in the primary tumor but not in the metastasis.</p><p id="Par13">We also checked for differences in telomere lengths between primary tumors and metastases in our cohort, but we could not detect telomere lengthening in our samples nor any significant alteration between primary tumor and metastases (Fig. <xref rid="MOESM1" ref-type="media">S2</xref>).</p></sec><sec id="Sec5"><title>Most siNETs lack strong candidates for early genomic drivers</title><p id="Par14">Prior studies stated that <italic>CDKN1B</italic> gene mutations are the most common driver mutation in siNETs with a frequency between 8%<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup> and 23%<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> of samples. We only detected a single <italic>CDKN1B</italic> non-silent mutation in our samples. Recently, TNRC6B mutations have been described as recurrent mutations, detected in 8% of siNET samples<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. We did not observe <italic>TNRC6B</italic> gene mutations in our cohort.</p><p id="Par15">As possible oncogenic mutations, we observed <italic>AHNAK</italic> and <italic>BCOR</italic> gene mutations with a higher frequency in metastasis samples (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>g). Both genes encode for known tumor suppressors, the first involved in the TGF&#x003b2; signaling pathway via R-Smad mediated downregulation of cell cycle<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, the latter in suppression of cell cycle and proliferation via Myc inhibition<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. <italic>AHNAK</italic> mutations have been reported in other entities of neuroendocrine neoplasms (neuroblastomas and adrenocortical carcinomas, both with a frequency below 5%<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>), whereas <italic>BCOR</italic> mutations have been previously found in siNETs with a frequency of 5.6%<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. However, we observed <italic>AHNAK</italic> and <italic>BCOR</italic> mutations only with a low recurrence and to a smaller extent in primary tumors. This suggests that they are acquired during tumor progression rather than drivers of the initial oncogenic transformation.</p><p id="Par16">We identified mutations on non-coding RNA (ncRNA) (Fig. <xref rid="MOESM1" ref-type="media">S3</xref>). Although it is difficult to interpret their functional effect on the gene product, their rarity and inconsistency among multiple tumors from the same patient (P10 and P28) suggest that ncRNA mutations are unlikely drivers of siNET emergence.</p><p id="Par17">In conclusion, we did not observe any frequent gene mutation that explains the initial oncogenic transformation in most siNET samples.</p></sec><sec id="Sec6"><title>siNET evolution implicates late-stage defective homologous repair</title><p id="Par18">Our cohort included seven pairs of samples each from one patient allowing us to investigate the siNET heterogeneity and evolution by analyzing shared mutations of these tumors (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a&#x02013;d). Four pairs (P25 primary tumor and metastases (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a), P14 primary tumor and metastases (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b), P8 primary tumor and lymph node metastasis (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>c), P12 lymph node and hepatic metastasis&#x000a0;(Fig. <xref rid="MOESM1" ref-type="media">S4</xref>g) showed a substantial number of shared mutations indicating a clear relationship for each pair originating from a common ancestral clone (Fig. <xref rid="MOESM1" ref-type="media">S4</xref>h). Mutations exclusively occurring either in the metastasis or the primary tumor demonstrate an ongoing divergent evolution.</p><p>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Evolution of siNETs and their mutational processes. (<bold>a</bold>&#x02013;<bold>d</bold>) Scatter plots of the predicted number of mutated alleles that are shared and sample-specific for matched primary and metastasis. (<bold>e</bold>) Definition of thresholds for predicted number of mutated alleles to determine shared (purple), primary-specific (blue), and metastasis-specific (red) mutations of the major clone. (<bold>f</bold>, <bold>g</bold>) Mutational signatures of shared and primary/metastasis-specific mutations. (<bold>f</bold>) Number of SNVs is indicated above each bar. (<bold>g</bold>) Tested using Kruskall-Wallis, *: <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></caption><graphic xlink:href="41598_2025_1912_Fig2_HTML" id="MO2"/></fig>
</p><p id="Par19">In one pair (P1 primary tumor and hepatic metastasis (Figs. <xref rid="Fig2" ref-type="fig">2</xref>d and <xref rid="MOESM1" ref-type="media">S4</xref>d,h)) only&#x02009;~&#x02009;1.5% of the metastatic clonal mutations were shared with the primary tumor. Modelling the mutated allele counts revealed that the metastatic lesion was derived from a primary subclone&#x000a0;(~&#x02009;21% clonality). Consistent with this finding of subclonal heterogeneity, we detected chromosome 18 loss only in the primary tumor but not in metastases, implying that the minor subclone giving rise to the metastasis did not harbor the chromosome 18 deletion.</p><p id="Par20">As previously mentioned, we detected SBS3, a mutational signature of defective HR DNA repair in our samples (Figs. <xref rid="Fig2" ref-type="fig">2</xref>e&#x02013;g, <xref rid="MOESM1" ref-type="media">S4</xref>i). To investigate if these mutations arise early in tumorigenesis, we took advantage of our genetically related matched pairs and analyzed SBS signatures from both the shared mutations and the primary/metastasis-specific mutations. Mutations that occur exclusively in either primary or metastatic lesions are acquired after formation of the most recent common ancestor of the tumor, whereas shared mutations occur early, before divergent evolution. Interestingly, SBS3 was not detected in the shared mutations but was present in the mutations specific to primaries or metastasis, suggesting that this signature is a late acquired characteristic of siNET evolution, consistent with observations in colorectal cancer<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. However, the precise role of the SBS signature in siNETs remains unclear, given the low mutational burden and lack of other genome instability indicators.</p><p id="Par21">In two pairs of samples (P28 two primary tumors and P10 primary tumor and hepatic metastasis) we found only a very limited number of shared mutations indicating that these tumors developed independently (Fig. <xref rid="MOESM1" ref-type="media">S4</xref>). This is in line with previous results and emphasizes that in certain, yet unknown conditions siNETs can develop independently out of different progenitors<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>.</p><p id="Par22">To assess if this condition is associated with bacterial infection, we screened for bacterial DNA but did not detect any specific amount of foreign DNA in our tumor samples, though our sequencing protocols are not necessarily suitable for bacterial DNA isolation. Previous studies have shown that colibactin, a genotoxin found in certain <italic>E. coli</italic> strains, has a significant impact on the development of colorectal cancer and leaves a specific mutational signature<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. However, we did not find residual mutational signatures of colibactin induced DNA mutations in our samples, arguing against an involvement of colibactin in siNET formation.</p><p id="Par23">Previously, it has been stated that loss of imprinting (LOI) of <italic>IGF2</italic> is a condition that enables siNET development<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> however, allele-specific expression analysis in our samples only supports <italic>IGF2</italic> LOI in few samples (Fig. <xref rid="MOESM1" ref-type="media">S5</xref>).</p></sec><sec id="Sec50"><title>Multi-focal tumors associated with pathogenic germline mutations in DNA repair genes&#x0feff;</title><p id="Par24">Next, we checked if germline mutations confer predisposition that enables siNET formation in a broader region of intestine. Interestingly, among our 32 siNET patients, three possessed ClinVar annotated pathogenic or likely pathogenic germline mutations in genes that belong to the Fanconi anemia DNA repair pathway (FANC genes). These mutations include a likely pathogenic <italic>FANCA</italic> mutation (rs769862233) in patient P19, a pathogenic <italic>FANCC</italic> mutation (rs104886459) in patient P12, and a pathogenic <italic>FANCM</italic> mutation (rs757391108) in patient P25 (Supplementary Table <xref rid="MOESM5" ref-type="media">4</xref>). The <italic>FANCA</italic> mutation was a point mutation in the splice acceptor site, and the <italic>FANCC</italic> and <italic>FANCM</italic> mutations were deletions that resulted in frameshifts. The mutations are present at extremely low frequencies in the population (allele freqnecies of 0.00004 and 0.00001 in ExAC for the <italic>FANCA</italic> and <italic>FANCM</italic> mutations, respectively). We did not observe any further pathogenic or likely pathogenic germline predispositions in our cohort. Interestingly, all three patients had multifocal siNETs. <italic>FANCA</italic>, <italic>FANCC</italic>, and <italic>FANCD</italic> genes encode for proteins that are part of the Fanconi anemia core complex, responsible for detection of DNA interstrand cross-links<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> and initiation of their repair with the help of the HR machinery<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>.</p><p id="Par25">Germline mutations in siNETs have been described previously with a frequency of 9&#x02013;11% and include mutations in <italic>ATM</italic>, <italic>RAD51C</italic>, <italic>MUTYH</italic>, and <italic>BLM</italic><sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. Interestingly, all four genes encode for known tumor suppressors involved in DNA repair<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref></sup>. Taken together, defective HR DNA repair seems to be a feature of siNET biology and could explain the broad range of chromosomal aberrations although the precise mechanism remains uncertain.</p><p id="Par26">In summary, our comprehensive genome analyses did not reveal commonly mutated genes. Furthermore, multifocal siNETs arose independently. Together, these observations indicate that initial siNET formation is not driven by a genetic event but rather by an unknown condition that affects a broader region of the intestine. However, impaired DNA repair seems to be a recurrent signature in siNET evolution as demonstrated by germline mutations in FANC genes and the occurrence of the defective HR DNA repair signature SBS3 in late acquired mutations.</p></sec><sec id="Sec7"><title>Low REST expression is a hallmark of siNETs</title><p id="Par27">To further understand underlying molecular mechanisms of siNET tumor biology, we performed bulk RNA sequencing of our tumor samples (Fig. <xref rid="MOESM1" ref-type="media">S1</xref>b). For deconvolution of tumor and non-tumor gene expression signatures, independent component analysis (ICA) was used. Independent component 3&#x000a0;(IC3) negatively correlates with tumor cell content (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a). Gene set enrichment analysis of IC3 identified enrichment of target genes of <italic>CDX2</italic>, a transcription factor that is highly and exclusively expressed in gut epithelium<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>, emphasizing IC3 as a component that distinguishes tumor from adjacent normal tissue gene expression (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b). Of note, CDX2 itself is expressed in tumors as well and does not correlate with tumor cell content reflecting its use as a marker of intestinal origin in case of cancer of unknown primary (Fig. <xref rid="MOESM1" ref-type="media">S6</xref>). Interestingly, IC3 is depleted of <italic>REST</italic>&#x000a0;(RE1-silencing transcription factor) target genes (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b). Indeed, expression of the transcription repressor <italic>REST</italic> negatively correlates with tumor cell content and is thus depleted in tumors (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>c). Western blot analyses confirmed the absence of REST in siNETs (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>d).</p><p>
<fig id="Fig3"><label>Fig. 3</label><caption><p>siNET gene expression resembles enteroendocrine cells. For deconvolution of tumor and non-tumor gene expression signatures independent component analysis was performed. (<bold>a</bold>) Independent component 3 of siNET expression anti-correlates with tumor cell content and (<bold>b</bold>) is depleted in REST target genes (<italic>GO-BP</italic> gene ontology biological process, <italic>TF</italic> transcription factor, <italic>p</italic>-values are adjusted using the Benjamini&#x02013;Hochberg procedure). The top enriched gene set are shown (Supplementary Table <xref rid="MOESM6" ref-type="media">5</xref>). (<bold>c</bold>) REST gene expression negatively correlates with tumor cell content and is therefore downregulated in siNETs. (<bold>d</bold>) Western Blot analysis of REST in normal tissue (tonsil and healthy small intestine) and siNET tissue of 3 samples from our cohort and 6 independent samples (<italic>P</italic> primary tumor, <italic>MH</italic> hepatic metastasis). (<bold>e</bold>) Marker genes that define EEC cell-type signature. (<bold>f</bold>, <bold>g</bold>) siNET gene expression was deconvoluted using NMF. (<bold>f</bold>) NMF factor 4 correlated with siNET marker genes, (<bold>g</bold>) resembles the EEC cell-type signature and (<bold>h</bold>) is associated with tumor cell content. (<bold>i</bold>) Expression of REST and Synaptophysin (SYP) in intestinal epithelial cells (<bold>j</bold>) Gene expression of EEC subtype markers in siNETs implicates enterochromaffin cells as potential cell-of-origin.</p></caption><graphic xlink:href="41598_2025_1912_Fig3_HTML" id="MO3"/></fig>
</p><p id="Par28"><italic>REST</italic> is a master transcription repressor of neuronal genes and a proposed tumor suppressor in several malignancies like Wilms Tumor, triple negative breast cancer and small cell lung cancer<sup><xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR45">45</xref></sup>. Low expression of <italic>REST</italic> is a novel transcriptomic signature of siNETs. However, this signature is not explained by genomic alterations.</p></sec><sec id="Sec8"><title>Gene expression profiles of siNETs resemble enteroendocrine cells (EECs) and implicates them as the cell of origin</title><p id="Par29">Beside a tumorigenic function, low expression of <italic>REST</italic> could also be inherited from the cell of origin of siNETs. Although it has been assumed since the early twentieth century that siNETs originate from EECs, the only evidence supporting this assumption is the morphological and immunohistochemical resemblance between the two<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. While others have also hypothesized that siNETs originate from EECs using molecular data<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> we have not encountered systemic cell of origin analysis that considered the cell types in the small intestine and EEC sub types. To elucidate the cell of origin, we performed non-negative matrix factorization (NMF) on the gene expression profiles of cell type-specific marker genes obtained from publicly available single-cell RNA sequencing (scRNA-seq) data of the human intestine<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Based on cell-type markers (Figs. <xref rid="Fig3" ref-type="fig">3</xref>e and <xref rid="MOESM1" ref-type="media">S7</xref>a) we obtained four factors where factor 4 correlated with enteroendocrine marker genes and shows the highest similarity to the EEC gene expression signature (Figs. <xref rid="Fig3" ref-type="fig">3</xref>f,g and <xref rid="MOESM1" ref-type="media">S7</xref>b). Additionally, this factor correlates with tumor cell content (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>h) thus implicating EECs as the cell of origin. Interestingly, not only the clinical biomarker of siNETs&#x02013;Synaptophysin&#x02014;followed the expected expression in EECs but also <italic>REST</italic> expression is low in EECs (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>i) suggesting that low expression of <italic>REST</italic> may be inherited from EECs, the cell of origin of siNETs.</p><p id="Par30">Due to the low number of EECs from non-fetal, healthy tissue in the scRNA-seq data, a deconvolution using the EEC subtypes could not be performed, however the expression of typical EEC subtype markers<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> (Fig. <xref rid="MOESM1" ref-type="media">S7</xref>d) in the siNET samples showed high expression of <italic>TPH1</italic> (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>j)&#x02014;a marker for enterochromaffin cells<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. <italic>TAC1</italic> was also highly expressed in all but a single sample, further supporting the hypothesis that enterochromaffin cells are the EEC subtype of origin. Interestingly the sample that had low <italic>TAC1</italic> expression also had a high <italic>NEUROG3</italic> expression pointing at a progenitor signature, however, this is confounded by the fact that this patient was the only one in the cohort that received chemotherapy.</p></sec></sec><sec id="Sec9"><title>Discussion</title><p id="Par31">In this study we analyzed the genome and transcriptome of 39 well differentiated siNETs. We found that siNETs are in general mutationally quiet without clear driver mutations explaining the initial oncogenic transformation. <italic>CDKN1B</italic> mutations were previously reported as a driver albeit with a low frequency<sup><xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref></sup>. We detected only one <italic>CDKN1B</italic> mutation, however this could be due to a low sample size. By analyzing multiple samples from one patient Elias et al. demonstrated that even in one patient <italic>CDKN1B</italic> mutations occurred inconsistently between multiple primary tumors. These results together suggest that <italic>CDKN1B</italic> mutations are enriched in siNETs but cannot explain exclusively siNET formation. We did not observe any other frequent gene mutation.</p><p id="Par32">In accordance with the literature, various chromosomal aberrations were detected in our siNET cohort, especially loss of chromosome 18. The functional relevance of chromosome 18 loss has been discussed longish and controversially with involvement of several tumor suppressors like <italic>DCC</italic>, Elongin A3, <italic>SMAD2</italic>, <italic>SMAD4</italic>, and <italic>MIR1-2</italic>, but so far, no conclusive results exist<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR51">51</xref>&#x02013;<xref ref-type="bibr" rid="CR53">53</xref></sup>. Elias et al. also demonstrated that 7 of 11 patients showed an inconsistency in chromosome 18 deletion across multiple primary samples and additionally, two more did not show chromosome 18 deletion<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. In line with that finding, we also observed an inconsistency in chromosome 18 loss in paired samples in one of our patients (P1, primary tumor and metastasis). These results suggest that tumors benefit from chromosome 18 deletion, but it is not necessary for initial oncogenic transformation, as in the same patient, some primary tumors exhibit chromosome 18 loss, and some do not. Furthermore, we observed a reduced prevalence of chromosome 18 deletion in metastatic lesions compared to primaries, suggesting a non-essential role of chromosome 18 deletion in tumor progression.</p><p id="Par33">In summary, siNETs display several chromosomal aberrations but do not possess any common driver mutations and can arise independently with no shared genetic background. This indicates that there is no early genetic event that clearly explains the initial oncogenic transformation from an EEC to a siNET cell for most cases. We assume that a larger region of healthy small intestine is subject to certain conditions that confer susceptibility to siNET generation. After this first step, observed genomic and chromosomic alterations provide selective advantage and allow progression and metastasizing after siNET formation. We looked for specific conditions that could predispose siNET development and found no evidence of bacterial infections, the genotoxin colibactin, telomere lengthening or loss of imprinting of <italic>IGF2</italic>. In three patients with multi-focal tumors, we found germline mutations in the FANC DNA repair pathway, strongly linked to HR DNA repair<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>, which could explain the high number of chromosomal alterations observed in siNETs. Consistent with our results, germline mutations in siNETs were previously described with a frequency of 9&#x02013;11% and include mutations in <italic>ATM</italic>, <italic>RAD51C</italic>, <italic>MUTYH</italic>, and <italic>BLM</italic><sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. Interestingly, all four genes are involved in DNA repair and partially interact with the FANC gene products<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref></sup>. Therefore, our results suggest a potential role of genetic predisposition in DNA repair-related pathways, although the precise way it operates remains to be elucidated.</p><p id="Par34">We analyzed the SBS mutation signatures in both shared and non-shared mutations in primary and metastasis pairs from the same patient<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. The defective HR DNA repair signature SBS3 only occurred in non-shared mutations, indicating that this mutational signature is a characteristic of late tumor stage. While we did not observe clear indications of large scale genomic instability in siNETs, elevated levels of the mutational signature of defective HR DNA repair in advanced siNETs is an interesting finding and a possible explanation why siNETs exhibit a high number of chromosomal alterations&#x02013;especially in the metastatic state&#x02014;and a more aggressive behavior over time with an increase of their Ki67 index<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Together, germline FANC mutations and somatic SBS3 signatures implicating defective DNA repair argue for considering novel therapeutic strategies, e.g. PARP inhibitors, and re-biopsies during the disease process to track the evolution of the tumor and adopt treatment decisions accordingly.</p><p id="Par35">We further investigated possible tumor initiating events at the transcriptomic level. RNA sequencing revealed EECs as the cell of origin of siNETs. Although, this was assumed for a long time<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>, evidence besides histological analyses and immunostaining was lacking. By analyzing the transcriptome of intestinal EECs and our siNETs we detected a strong transcriptomic similarity arguing for EECs as the cell of origin. Further analysis provided evidence that serotonin producing enterochromaffin cells, an EEC subtype, are the cell of origin.</p><p id="Par36">Additionally, we detected low expression of <italic>REST</italic> as a hallmark of siNETs. <italic>REST</italic>, a transcriptional repressor of neuronal genes, has been described as a tumor suppressor in several malignancies<sup><xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR45">45</xref></sup>. Also, for colon cancer a tumor suppressing function was described where a reduced <italic>REST</italic> expression resulted in enhanced activity of the PI3K/AKT/mTOR signaling pathway, the target of Everolimus, a main therapeutic agent in siNET treatment<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. Beside the tumor suppressing function, <italic>REST</italic> is also a key player in regulation of transdifferentiation of epithelial malignancies: It was previously shown that downregulation of <italic>REST</italic> in hormone refractory prostate cancer and small cell lung cancer caused a transdifferentiation towards a neuroendocrine tumor state with expression of neuroendocrine markers like Synaptophysin<sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. Furthermore, our data suggests that low expression of <italic>REST</italic> could be inherited from the cell of origin as <italic>REST</italic> is already suppressed in EECs and observed genomic alterations did not explain low <italic>REST</italic> expression. Conducting scRNA-seq of both EECs and siNET cells would allow for more accurate analyses by identification of the transcriptomic differences between the two, however, this is complicated by the low number of EECs in the healthy epithelium. While this calls for strategies to enrich for the EEC population for targeted phenotypic characterization of the cell of origin, this is currently impeded by a lack of robust surface markers for EECs to enable enrichment. Furthermore, since most siNETs lack clear genomic drivers, we believe ongoing research should also explore epigenomic perturbations in siNETs compared to EECs&#x02014;their cell of origin.</p></sec><sec id="Sec10"><title>Methods</title><sec id="Sec11"><title>Clinical cohort</title><p id="Par37">32 patients underwent surgery for siNETs or their metastases. The clinical characteristics are given in Supplementary Table <xref rid="MOESM2" ref-type="media">1</xref>. Pathological analysis and confirmation of G1/G2 NET diagnosis were performed following clinical routine. A tumor piece and adjacent normal tissue samples were collected at surgery and directly frozen in liquid nitrogen.</p><p id="Par38">The collection of tissue samples for this study was approved by the Ethics Committee of the Charit&#x000e9;&#x02013;Universit&#x000e4;tsmedizin Berlin (No EA1/229/17). All patients received in-person as well as written information about the study. Informed consent was obtained and documented by signing a document. All methods were performed in accordance with the relevant guidelines and regulations.</p></sec><sec id="Sec12"><title>Tissue homogenization</title><p id="Par39">For preservation, the frozen tissues were transitioned into a minimum of 10 volumes of RNAlater&#x02122;-ICE (Invitrogen&#x02122;, ThermoFisher Scientific, MA, United States) at&#x02009;&#x02212;&#x02009;70&#x000a0;&#x000b0;C or&#x02009;&#x02212;&#x02009;80&#x000a0;&#x000b0;C. For the bead-based homogenization the tissue sections were transferred in Precellys Soft tissue homogenizing tubes (Soft tissue homogenizing CK14&#x000a0;Lysis kit; Bertin Technologies SAS, FRANCE) pre-filled with ceramic beads and lysis buffer. The samples were homogenized using the Precellys Evolution Homogenizer (Bertin Technologies SAS, FRANCE). The homogenizer was operated at 4500&#x000a0;rpm of 10&#x000a0;s run time and using the cooling-mode for RNA samples. For DNA samples three cycles of 20&#x000a0;s run time at 7500&#x000a0;rpm were used, and a 30&#x000a0;s break interval between the cycles.</p></sec><sec id="Sec13"><title>RNA extraction</title><p id="Par40">For isolation of total RNA, the automated high-throughput magnetic-bead extraction MagMAX&#x02122; <italic>mir</italic>Vana&#x02122; Total RNA Isolation Kit (Thermofisher Scientific, Waltham, MA, United States) was used with the King Fisher Flex system. The Kit also contains reagents for efficient, complete digestion of DNA by TURBO&#x02122; DNase (2&#x000a0;U/&#x003bc;l) along with removal of the enzyme. RNA concentration was quantified by Qubit&#x02122; 3 Fluorometer (Invitrogen&#x02122;, ThermoFisher Scientific, MA, United States) in combination with Qubit RNA BR Assay Kit (Invitrogen&#x02122;, ThermoFisher Scientific, MA, United States) and the RNA quality was verified based on RNA Integrity Number (RIN) scores estimated using RNA Screen Tape System on the 2200 Tape Station (Agilent Technologies, CA, United States). For the library preparation using the Poly(A) mRNA enrichment a RIN score of at least 7 (RIN&#x02009;&#x0003e;&#x02009;&#x02009;=&#x02009;7) was required.</p></sec><sec id="Sec14"><title>Extraction of genomic DNA</title><p id="Par41">Isolation of genomic DNA from tissues was done using the MagMAX DNA Multi-Sample Ultra 2.0 on the Thermo Scientific&#x02122; KingFisher&#x02122; Flex Duo system (Applied Biosystems, ThermoFisher Scientific, Waltham, Massachusetts, United States). Extracted genomic DNA was quantified with the Quant-iT double-stranded genomic Broad Range DNA assay (Invitrogen&#x02122;, ThermoFisher Scientific, Waltham, Massachusetts, United States) on the FLUOstar<sup>&#x000ae;</sup>&#x000a0;Omega fluorescence plate reader (BMG Labtech, Ortenberg, Germany). DNA integrity and size in base pairs (bp) were analyzed on the Agilent&#x02122; 4200 TapeStation&#x02122; System with a Genomic DNA ScreenTape&#x02122; device (Agilent Technologies, CA, United States).</p></sec><sec id="Sec15"><title>WGS library preparation and sequencing</title><p id="Par42">For library preparation the TruSeq<sup>&#x000ae;</sup> Nano DNA Library Prep kit, including IDT for Illumina TruSeq DNA UD Indexes, (8 nucleotides; 96 Indexes; 96 Samples) (Illumina, CA, United States) was used. Library Preparation was performed according to the manufacturer&#x02019;s instructions. Because of a genomic DNA input of 100&#x000a0;ng for the library preparation, the initial concentration was set between 15 and 25&#x000a0;ng/ul and initially sheared by sonication on the Covaris ME220 (Covaris Inc., Perkin Elmer, MA, United States) using the settings specified for a fragment size of 350&#x000a0;bp.</p><p id="Par43">The preparation protocol was adapted to the Biomek i7 workstation (Beckman Coulter, CA, United States), including the PCR steps. Enrichment was performed using 7 cycles of PCR, according to the manufacturer&#x02019;s recommendations. To assess the quality of the libraries, the fragment size was verified by checking the library size distribution (target insert size 550&#x000a0;bp) on an Agilent Technology Tape Station using the D5000 assay for analyzing double-stranded DNA molecules from 100 to 5,000 base pairs. The libraries were firstly quantified using Qubit 3.0 Fluorometer and additionally analyzed by the KAPA Library Quantification Kit (Roche, IN, United States), including NGS platform-specific library quantification primer on a Roche<sup>&#x000ae;</sup> LightCycler 480.</p><p id="Par44">Libraries were sequenced on the Illumina<sup>&#x000ae;</sup> NovaSeq 6000&#x02122; system using the S4 reagent Kit (paired end; 2&#x02009;&#x000d7;&#x02009;150&#x000a0;bp reads). The number of libraries per flow cell was based on the desired minimum coverage for the individual sample type: 30&#x02009;&#x000d7;&#x02009;for controls; 60&#x02009;&#x000d7;&#x02009;for tumor samples.</p></sec><sec id="Sec16"><title>WTS library preparation and sequencing</title><p id="Par45">For PolyA mRNA enrichment by the NEBNext Poly(A) mRNA Magnetic Isolation Module (New England Biolabs) an amount of 150&#x000a0;ng of high-quality RNA samples with a RIN score of at least 7 (RIN&#x02009;&#x0003e;&#x02009;&#x02009;=&#x02009;7) are required. NEBNext Ultra II Directional RNA Lib-Prep Kit for Illumina and the NEBNext Multiplex Oligos for Illumina Set 1 (96 Unique Dual Index Primer Pairs) (New England Biolabs) were used for the library preparation. All procedures were performed according to the protocols suggested by the manufacturers and adapted to the Biomek i7 workstation (Beckman Coulter, CA, United States). The fragmentation time and clean up conditions were set resulting in an insert size about 300 base pairs for the libraries. The concentration of the libraries was measured using Invitrogen Quant-iT dsDNA BR Assay (FisherScientific) and the microplate reader FLUOstar Omega (BMG Labtech, Germany) and analyzed on 4200 Tape Station (Agilent Technologies) using the High Sensitivity D1000 assay. Additionally, the libraries were analyzed by the KAPA Library Quantification Kit (Roche, IN, United States), including NGS platform-specific library quantification primer on a Roche<sup>&#x000ae;</sup> LightCycler 480.</p><p id="Par46">Libraries were sequenced on the Illumina<sup>&#x000ae;</sup> NovaSeq 6000&#x02122; system using the S4 reagent Kit (paired end; 2&#x02009;&#x000d7;&#x02009;150&#x000a0;bp reads). The number of libraries per S4 flow cell was based on at least 100 million reads per transcriptome library.</p></sec><sec id="Sec17"><title>Western blot</title><p id="Par47">NET tissue was intensively washed with PBS (Gibco), lysed with RIPA buffer (Thermo Fischer Scientific) containing a protease inhibitor cocktail (cOmplete&#x02122; Mini, Roche) and sonication (10&#x000a0;s, 60% intensity). The proteins were separated by SDS-PAGE (10&#x02013;12% Tris-Glycin, WedgeWell&#x02122;, Invitrogen) and transferred onto nitrocellulose membranes (0.2&#x000a0;&#x000b5;m, #1620112, Bio-Rad) that were blocked with 5% nonfat dry milk. Afterwards the membranes were incubated with primary antibodies against REST (1:2000, AK #22242, Proteintech) and &#x003b1;-tubulin (1:1000, #T9026, Sigma) overnight at 4&#x000a0;&#x000b0;C, followed by incubation with secondary anti-rabbit IgG antibody (1:10000, #111-035-045, Jackson Immuno Research) and secondary anti-mouse IgG antibody (1:10000, #AB_2340061, Jackson Immuno Research), respectively, for 1&#x000a0;h at room temperature. Detection was performed with SuperSignal&#x02122; West Dura Extended Duration Substrate (Thermo Fisher Scientific) using the Molecular Imager<sup>&#x000ae;</sup> VersaDoc&#x02122; and quantified with Image Lab&#x02122; software (Bio-Rad). The presented western blot contains 3 samples from our cohort (P10, P11, and P13) and 6 independent samples (3 primary siNETs and 3 hepatic metastases of siNETs).</p></sec><sec id="Sec18"><title>Whole-genome sequencing alignment</title><p id="Par48">Whole genome sequencing reads were aligned with the DKFZ alignment and QC workflow&#x000a0;(v1.2.73-201, <ext-link ext-link-type="uri" xlink:href="https://github.com/DKFZ-ODCF/AlignmentAndQCWorkflows">https://github.com/DKFZ-ODCF/AlignmentAndQCWorkflows</ext-link>). Briefly, the reads were mapped using <italic>bwa mem</italic> (v0.7.15)<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> to the human reference genome build 37 (hs37d5) with a base quality threshold of 0. Next, the alignments were converted to BAM format and sorted by coordinates using <italic>samtools</italic>&#x000a0;(v0.1.19)<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> before marking duplicates using <italic>sambamba</italic>&#x000a0;(v0.6.5)<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> with compression set to 0.</p></sec><sec id="Sec19"><title>Small variant identification</title><sec id="Sec20"><title>Single nucleotide variant calling</title><p id="Par49">Single nucleotide variants (SNVs) were called with the DKFZ SNV calling workflow&#x000a0;(v1.2.166-3, <ext-link ext-link-type="uri" xlink:href="https://github.com/DKFZ-ODCF/SNVCallingWorkflow">https://github.com/DKFZ-ODCF/SNVCallingWorkflow</ext-link>). Briefly, <italic>samtools</italic> (v0.1.19)<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> and <italic>bcftools</italic>&#x000a0;(<italic>htslib</italic> v0.2.5<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>) were used to identify SNVs and germline mutations were marked by comparing tumor to matched control samples. The quality of each SNV was characterized by checking for overlap with repeats, DAC blacklisted regions, DUKE excluded regions, self-chain regions, segmental duplicate records from ENCODE<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, and the presence of PCR or strand biases.</p></sec><sec id="Sec21"><title>Insertion and deletion calling</title><p id="Par50">Indels were identified using the DKFZ indel calling workflow&#x000a0;(v2.4.1-1, <ext-link ext-link-type="uri" xlink:href="https://github.com/DKFZ-ODCF/IndelCallingWorkflow">https://github.com/DKFZ-ODCF/IndelCallingWorkflow</ext-link>). <italic>Platypus</italic><sup><xref ref-type="bibr" rid="CR63">63</xref></sup> was used to identify indels and the internal confidence call was used for filtering indels with a score above 8.</p></sec><sec id="Sec22"><title>Rescue of tumor-in-normal mutations</title><p id="Par51">Tumor in Normal Detection Analysis (TiNDA, <ext-link ext-link-type="uri" xlink:href="https://github.com/NagaComBio/TiNDA">https://github.com/NagaComBio/TiNDA</ext-link>) was used as previously described in Ishaque et al.<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> to rescue mutations that were filtered as germline due to contamination of adjacent normal tissue with tumor DNA. All TiNDA rescued clusters were manually checked, and in case that clustering did not correctly identify the tumor-in-normal cluster mutations were manually rescued.</p></sec><sec id="Sec23"><title>Tumor mutational burden and hypermutated regions</title><p id="Par52">The tumor mutational burden (TMB) was calculated as the number of somatic SNVs and InDels in coding regions divided over the summed lengths of distinct non-overlapping coding regions (35,345,952&#x000a0;bp) in Gencode v19 gene models.</p><p id="Par53">Hypermutated regions which are indicative for kataegis events were identified by calculating the intermutational distance of SNVs. Genes that overlapped a region containing at least 6 SNVs with an average intermutational distance below 1000&#x000a0;bp were classified as hypermutated.</p></sec><sec id="Sec24"><title>Structural variation calling</title><p id="Par54">To identify structural variants the DKFZ Sophia workflow (v2.2.3, <ext-link ext-link-type="uri" xlink:href="https://github.com/DKFZ-ODCF/SophiaWorkflow">https://github.com/DKFZ-ODCF/SophiaWorkflow</ext-link>) was employed. Structural variation (SV) candidates were generated by <italic>SOPHIA</italic> (v35) on the basis of <italic>bwa-mem</italic> supplementary alignments. The candidates are further filtered by comparison to a background database of normal controls generated from over 3,000 patients. The GENCODE V19 gene annotations were used to annotate SVs within genic regions and SVs were filtered for a minimum &#x02018;clonalityRatio&#x02019; of 0.1 for both breakpoints.</p></sec><sec id="Sec25"><title>Copy number aberrations</title><p id="Par55">Copy number aberrations (CNAs) were called using the DKFZ ACEseq Workflow&#x000a0;(v1.2.8-4, <ext-link ext-link-type="uri" xlink:href="https://github.com/DKFZ-ODCF/ACEseqWorkflow">https://github.com/DKFZ-ODCF/ACEseqWorkflow</ext-link>). <italic>ACEseq</italic><sup><xref ref-type="bibr" rid="CR64">64</xref></sup> determines tumor ploidy, chromosomal copy numbers, and tumor cell content (tcc) based on coverage ratios and B-allele-frequencies (BAF) of heterozygous SNPs. Genome segmentation was estimated by integration of previously identified SVs.</p><p id="Par56">All purity and ploidy results were manually checked and corrected if the estimated tcc and ploidy did not sufficiently fit the BAF and coverage profiles.</p></sec><sec id="Sec26"><title>Frequency of copy number aberrations</title><p id="Par57">To calculate the frequency of CNAs across multiple samples the <italic>ACEseq</italic> output was transformed to an appropriate format to be processed using <italic>GISTIC2.0</italic> (v2.0.23)<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> with the provided hg19 reference genome file.</p></sec><sec id="Sec27"><title>Mutational signature analysis</title><p id="Par58">Mutational signature analysis for SNVs and indels was performed using <italic>YAPSA</italic> (v1.19.0)<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. The mutational catalogue was build using the <italic>BSgenome.Hsapiens.UCSC.hg19</italic> (<ext-link ext-link-type="uri" xlink:href="https://doi.org/">https://doi.org/</ext-link>10.18129/B9.bioc.BSgenome.Hsapiens.UCSC.hg19) (v1.4.3) as reference and decomposed jointly for all samples in &#x02018;consensus&#x02019; mode. <italic>YAPSA</italic> is based on the COSMIC Mutational Signatures v3.0 and only the real signatures were included (i.e. artificial signatures are not taken into account) in the decomposition together with their optimized signature cutoffs provided by the package.</p><p id="Par59">To evaluate the presence of the Colibactin signature it was downloaded from the original publication<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> and added to the signature catalogue used by <italic>YAPSA</italic>, and the previously described analysis was repeated with the same parameters.</p><p id="Par60">To analyze the copy number signatures from Steele et al.<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, copy number profiles were computed using <italic>ASCAT</italic> (v3.0.0)<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> to match the copy number calls used to extract these signatures. Briefly, <italic>ASCAT</italic> was run for WGS by extracting allele counts at specific loci with <italic>ascat.prepareHTS</italic> and calculating logR and BAF values. logR values were corrected with <italic>ascat.correctLogR</italic>, and segmentation performed with <italic>ascat.aspcf</italic>. Copy numbers and purities were calculated with <italic>ascat.runAscat</italic> limiting the <italic>max_ploidy</italic> to 2.5 and setting <italic>gamma</italic> to 1 as per the documentation. The relevant reference files for loci, alleles, GC correction and replication timing were downloaded for hg19 following the documentation.</p><p id="Par61">Copy number signatures were analyzed using the <italic>SigProfiler</italic> suite. The mutational catalogue was extracted using <italic>CNVMatrixGenerator.generateCNVMatrix</italic> from <italic>SigProfilerMatrixGenerator</italic>&#x000a0;(v1.2.12)<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> and the 21 non-artefactual CN signatures were assigned using <italic>Analyzer.cosmic_fit</italic> from <italic>SigProfilerAssignment</italic> (v0.0.13)<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>.</p></sec><sec id="Sec28"><title>Telomere content analysis</title><p id="Par62">To analyze telomere content of tumor and normal tissue, TelomereHunter&#x000a0;(v1.1.0)<sup><xref ref-type="bibr" rid="CR71">71</xref></sup> was run with both, tumor and control bam files. To correct for the tumor cell content (tcc) of tumor samples the estimated telomere content was adjusted using the formula:</p><p>
<disp-formula id="Equa"><alternatives><tex-math id="d33e1605">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$telomere_{corrected} = \frac{{telomere_{tumor} - telomere_{control} *\left( {1 - tcc} \right)}}{tcc}.$$\end{document}</tex-math><graphic xlink:href="41598_2025_1912_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>
</p></sec><sec id="Sec29"><title>Tumor heterogeneity analysis</title><p id="Par63">To analyze tumor heterogeneity using multiple samples of the same patient, small variant (SNVs and indels) positions were evaluated for clonality. First, genomic positions of small variants across all tumor samples of a patient were merged, and pileups generated using <italic>samtools mpileup</italic>&#x000a0;(v1.13)<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. The variant allele fraction was calculated for each sample and corrected for tumor copy number and tumor cell content (tcc) to calculate the predicted number of mutated alleles using the formula:</p><p>
<disp-formula id="Equb"><alternatives><tex-math id="d33e1624">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Alleles_{mutated} = VAF*\frac{CN*tcc}{{CN*tcc + 2*\left( {1 - tcc} \right)}}*CN.$$\end{document}</tex-math><graphic xlink:href="41598_2025_1912_Article_Equb.gif" position="anchor"/></alternatives></disp-formula>
</p><p>where <inline-formula id="IEq1"><alternatives><tex-math id="d33e1632">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Alleles_{mutated }$$\end{document}</tex-math><inline-graphic xlink:href="41598_2025_1912_Article_IEq1.gif"/></alternatives></inline-formula> refers to the predicted number of mutated alleles, previously referred to as the mutation copy number<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. All SNVs with coverage between 20 and 250 reads (to exclude lowly and highly covered regions) were split into metastasis-specific, tumor-specific, and shared mutations per patient depending on athreshold of 0.5 Alleles<sub>mutated</sub>. The resulting clusters were filtered for a minimum size of 100 SNVs (to avoid noisy deconvolution) and mutational signature analysis was performed as previously described. Difference in normalized signature exposure between the clusters was tested using a Kruskall-Wallis rank sum test. To further validate the results using a different mutational signature deconvolution method we also applied <italic>SigProfiler Assignment</italic> (v0.1.8)<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> using the <italic>Analyzer.cosmic_fit</italic> function.</p></sec><sec id="Sec30"><title>Germline predisposing mutations</title><p id="Par64">To identify potential tumor predisposition from germline mutations or single nucleotide polymorphisms (SNPs) identified in normal whole genome sequencing samples we used <italic>CPSR</italic> (<italic>PCGR</italic> v1.0.3)<sup><xref ref-type="bibr" rid="CR73">73</xref></sup> to identify pathogenic and likely pathogenic variants using the CPSR exploratory cancer predisposition panel&#x000a0;(panel-ID 0) consisting of 433 genes curated from the TCGA&#x02019;s Germline Study, COSMIC&#x02019;s Cancer Gene Census v100, Genes from all Genomics England PanelApp panels for inherited cancers and tumor syndromes, as well as DNA repair genes, and additional genes deemed relevant for cancer predisposition (i.e. contributed by CPSR users).</p></sec><sec id="Sec31"><title>Transposable element insertion</title><p id="Par65"><italic>xTea</italic>&#x000a0;(v0.1.7)<sup><xref ref-type="bibr" rid="CR74">74</xref></sup> was used to evaluate tumor samples for Transposable element (TE) insertions. The tumor samples were processed in case&#x02013;control mode of <italic>xtea_hg19</italic> analyzing L1, Alu, and SVA insertions. The reference genome was the same as for WGS alignment and as gene annotation the GENCODE release 33 for GRCh37 was used.</p></sec><sec id="Sec32"><title>Foreign DNA detection</title><p id="Par66">To detect foreign DNA, such as bacterial or viral sequences, we used <italic>Kraken2</italic>&#x000a0;(v2.1.2)<sup><xref ref-type="bibr" rid="CR75">75</xref></sup> and <italic>Bracken</italic>&#x000a0;(v2.6.1)<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>. Briefly, the default <italic>kraken2</italic> database was built using <italic>kraken2-build</italic> with the <italic>standard</italic> flag. All read pairs with at least one unaligned read were extracted from the BAM-files using <italic>samtools</italic> (v1.14)<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> and converted to fastq files for read 1 and 2 using <italic>bedtools</italic> (v2.30.0)<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. <italic>Kraken2</italic> was run in paired-end mode and the output and report with aggregated counts per clade written to file. Genus abundances were estimated with <italic>bracken</italic> after building a database with <italic>k</italic>-mer length of 35 and read-length of 150 (matching our sequencing protocol) with <italic>bracken-build</italic>.</p></sec><sec id="Sec33"><title>RNA sequence alignment and gene expression quantification</title><p id="Par67">The DKFZ RNAseq workflow&#x000a0;(v1.3.0-1, <ext-link ext-link-type="uri" xlink:href="https://github.com/DKFZ-ODCF/RNAseqWorkflow">https://github.com/DKFZ-ODCF/RNAseqWorkflow</ext-link>) was used to align the reads from RNA sequencing and quantify gene expression. Briefly, reads were aligned against a STAR index generated for reference genome hs37d5 and aligned in 2 pass mode using <italic>STAR</italic>&#x000a0;(v2.5.3a)<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. The alignment was converted to BAM format and sorted by coordinates using <italic>samtools</italic>&#x000a0;(v1.6)<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> and duplicate reads were marked with <italic>sambamba</italic>&#x000a0;(v0.6.5)<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> but not removed. To quantify gene expression <italic>featureCounts</italic>&#x000a0;(<italic>Subread</italic> v1.5.1)<sup><xref ref-type="bibr" rid="CR79">79</xref></sup> was run with the GENCODE V19 gene model, counting reads non-strand specific over exon features, without exclusion of duplicate reads and only considering pairs with two uniquely mapping fragments (quality score of 255). For transcripts per million (TPM) calculation, gene counts on the X, Y, and MT chromosomes as well as rRNA and tRNA were excluded from library size estimation to avoid biases.</p></sec><sec id="Sec34"><title>Unsupervised gene expression analysis</title><p id="Par68">To analyze the tumor gene expression in an unsupervised manner, independent component analysis&#x000a0;(ICA) was employed. First, gene expression counts were filtered for protein-coding genes that were detected in at least 3 samples. The <italic>rlog</italic> transform from <italic>DESeq2</italic>&#x000a0;(v1.34.0)<sup><xref ref-type="bibr" rid="CR80">80</xref></sup> was used with default parameters to stabilize the variance. The 1000 most variable genes were selected and the <italic>FastICA</italic> implementation from <italic>scikit-learn</italic> (v1.0.1)<sup><xref ref-type="bibr" rid="CR81">81</xref>,<xref ref-type="bibr" rid="CR82">82</xref></sup> was used to generate a latent space with 7 components.</p></sec><sec id="Sec35"><title>Gene set enrichment analysis</title><p id="Par69">To analyze the different gene signatures identified via ICA gene set enrichment analysis (GSEA)<sup><xref ref-type="bibr" rid="CR83">83</xref></sup> was run using ICA gene weights of each factor as ranking criterion. <italic>MIGSA</italic> (v1.18.0, <ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/3.14/bioc/html/MIGSA.html">https://bioconductor.org/packages/3.14/bioc/html/MIGSA.html</ext-link>) was used to download the gene set collections <italic>ChEA_2016, ENCODE_and_ChEA_Consensus_TFs_from_ChIP-X, TRRUST_Transcription_Factors_2019, ClinVar_2019, MSigDB_Hallmark_2020,</italic> and <italic>MSigDB_Oncogenic_Signatures</italic> from Enrichr<sup><xref ref-type="bibr" rid="CR84">84</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://amp.pharm.mssm.edu/Enrichr">http://amp.pharm.mssm.edu/Enrichr</ext-link>). <italic>gseGO</italic> and <italic>gseKEGG</italic> from <italic>clusterProfiler</italic>&#x000a0;(v4.2.0)<sup><xref ref-type="bibr" rid="CR85">85</xref></sup> and <italic>gsePathway</italic> from <italic>ReactomePA</italic>&#x000a0;(v1.38.0)<sup><xref ref-type="bibr" rid="CR86">86</xref></sup> were used to analyze biological process gene ontologies, Kegg pathways, and Reactome pathways, respectively. All prior downloaded gene sets were analyzed using <italic>GSEA</italic> from <italic>clusterProfiler</italic>. The Benjamini&#x02013;Hochberg procedure was used for multiple testing correction per gene set collection as implemented in <italic>clusterProfiler</italic>.</p></sec><sec id="Sec36"><title>Allele specific expression analysis of IGF2</title><p id="Par70">To evaluate the loss of imprinting (LOI) at the IGF2 locus, we estimated the allele-specific expression&#x000a0;(ASE) using heterozygous SNPs identified from whole genome sequencing data. Heterozygous SNPs were selected from the <italic>ACEseq</italic> output (see section Copy number aberrations) and filtered to be within twofold of the average coverage of the respective sample and within a protein coding exon (GENCODE V19) using <italic>bcftools</italic> (<italic>htslib</italic><sup><xref ref-type="bibr" rid="CR61">61</xref></sup> v1.16). SNPs were sorted, normalized (without removing duplicates), and converted to compressed BCF before concatenating all chromosomes per sample to a compressed VCF using <italic>bcftools</italic>. The Genome Analysis Toolkit (v4.3.0.0)<sup><xref ref-type="bibr" rid="CR87">87</xref></sup>
<italic>ASEReadCounter</italic> module was used with a minimum mapping quality of 255 and a minimum base quality of 10 to estimate the ASE on the previously identified SNPs. The results were filtered by removing SNPs with a depth below 10, more than 3 &#x02018;otherBases&#x02019;, more &#x02018;otherBases&#x02019; than &#x02018;altCount&#x02019; and &#x02018;refCount&#x02019;, and all HLA genes. SNPs were then aggregated per gene by averaging the expression ratio of the allele with the most counts i.e. <inline-formula id="IEq2"><alternatives><tex-math id="d33e1896">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{{counts_{allele} }}{{counts_{total} }}$$\end{document}</tex-math><inline-graphic xlink:href="41598_2025_1912_Article_IEq2.gif"/></alternatives></inline-formula>.</p></sec><sec id="Sec37"><title>Cell of origin identification</title><p id="Par71">To identify the cell of origin, public scRNA-seq data was used to compare tumor gene expression to small intestinal cell-type signatures. Normalized gene expression for epithelial cell lineages was downloaded from <ext-link ext-link-type="uri" xlink:href="http://www.gutcellatlas.org">www.gutcellatlas.org</ext-link><sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. The data was subset to only include healthy, non-fetal samples and rare cell types were aggregated to their parental lineage (i.e. all enteroendocrine cells were merged, Goblet cell subtypes were merged, Stem cells and transiently amplifying cells were merged). The genes were subset to protein-coding genes identified in the tumor gene expression analysis and the top 10 marker genes per cell type were identified by using the first ranking genes using the <italic>rank_genes_group</italic> function with &#x02018;wilcoxon&#x02019; as method and then filtering for a minimum log-fold change of 2 using <italic>filter_rank_genes_groups</italic> from <italic>scanpy</italic>&#x000a0;(v1.9.1)<sup><xref ref-type="bibr" rid="CR88">88</xref></sup>.</p><p id="Par72">The <italic>rlog</italic>-transformed tumor gene expression was subset to the previously selected marker genes, normalized using the <italic>normalize</italic> function and decomposed into 4 factors using <italic>NMF</italic> (both <italic>scikit-learn</italic>&#x000a0;v1.0.1) using an L1-ratio of 0 and <italic>alpha_W</italic> of 10<sup>&#x02212;3</sup>. The cosine similarity was calculated for the NMF factors and the cell type-averaged single-cell gene expression signatures.</p></sec></sec></sec><sec id="Sec38" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2025_1912_MOESM1_ESM.docx"><caption><p>Supplementary Figures.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41598_2025_1912_MOESM2_ESM.xlsx"><caption><p>Supplementary Table&#x000a0;1.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41598_2025_1912_MOESM3_ESM.xlsx"><caption><p>Supplementary Table 2.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41598_2025_1912_MOESM4_ESM.xlsx"><caption><p>Supplementary Table 3.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41598_2025_1912_MOESM5_ESM.xlsx"><caption><p>Supplementary Table 4.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41598_2025_1912_MOESM6_ESM.xlsx"><caption><p>Supplementary Table 5.</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Felix Bolduan and Niklas M&#x000fc;ller-B&#x000f6;tticher contributed equally.</p></fn><fn><p>Bertram Wiedenmann, Michael Sigal, and Naveed Ishaque jointly supervised the study.</p></fn></fn-group><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-025-01912-4.</p></sec><ack><title>Acknowledgements</title><p>First and foremost, we thank the patients and their families for sample donation. We thank Philipp Strubel, Sven Twardziok and Harald Wagener of the BIH Center for Digital Health for data management support and compute infrastructure.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Formal analysis of WGS and RNA-seq data: NMB, FB, OD, and NI; Acquisition and provision of study materials: IE and BW; Pathological analyses: CAK, AL and DH; DNA and RNA isolation and sequencing: TZ, MJ, and UU; Western Blot analysis: YG and AW, Data Curation: FB and NMB; Conceptualization and Supervision: NI, RE, BW, CR, and MS; Funding acquisition: NI, RE, MS, BW, FT and CR; Writing&#x02014;Original Draft: FB and NMB; Visualization: NMB; Review and Editing: all authors.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL.</p><p>The authors acknowledge the financial support by the Federal Ministry of Education and Research of Germany in the framework of SAGE (Project Number 031L0265), the BIH Personalized Digital Oncology (PeDiOn) program. MS received funding from the DFG (DFG Si 1984 4/1), Horizon Europe ERC (Starting Grant REVERT (ERC Grant Number 101040453)), The Einstein Foundation (EC3R Einstein Center) and the BMBF (PACE Therapy). Additionally, the authors thank Gunther Speidel (&#x02020;) and Dr. Monika Gunzenhauser for generous donations.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Single-cell gene expression data of small intestines was obtained from <ext-link ext-link-type="uri" xlink:href="http://www.gutcellatlas.org">www.gutcellatlas.org</ext-link> (49). Aggregated non-sensitive results are available as tab-separated value tables to Zenodo (10.5281/zenodo.15084372).</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>All code used to process aggregated results can be downloaded as Jupyter Notebooks from GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/HiDiHlabs/siNET_omics_analysis">https://github.com/HiDiHlabs/siNET_omics_analysis</ext-link>.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par73">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Pavel</surname><given-names>M</given-names></name><name><surname>&#x000d6;berg</surname><given-names>K</given-names></name><name><surname>Falconi</surname><given-names>M</given-names></name><name><surname>Krenning</surname><given-names>EP</given-names></name><name><surname>Sundin</surname><given-names>A</given-names></name><name><surname>Perren</surname><given-names>A</given-names></name><etal/></person-group><article-title>Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up&#x02020;&#x02020;approved by the ESMO Guidelines Committee: August 2007, last update March 2020. This publication supersedes the previously published version&#x02014;Ann Oncol. 2012;23(suppl 7):vii124&#x02013;vii130</article-title><source>Ann. Oncol.</source><year>2020</year><volume>31</volume><issue>7</issue><fpage>844</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1016/j.annonc.2020.03.304</pub-id><pub-id pub-id-type="pmid">32272208</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Pavel, M. et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up&#x02020;&#x02020;approved by the ESMO Guidelines Committee: August 2007, last update March 2020. This publication supersedes the previously published version&#x02014;Ann Oncol. 2012;23(suppl 7):vii124&#x02013;vii130. <italic>Ann. Oncol.</italic><bold>31</bold>(7), 844&#x02013;860 (2020).<pub-id pub-id-type="pmid">32272208</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Aaltonen</surname><given-names>LA</given-names></name><name><surname>Abascal</surname><given-names>F</given-names></name><name><surname>Abeshouse</surname><given-names>A</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Adams</surname><given-names>DJ</given-names></name><name><surname>Agrawal</surname><given-names>N</given-names></name><etal/></person-group><article-title>Pan-cancer analysis of whole genomes</article-title><source>Nature</source><year>2020</year><volume>578</volume><issue>7793</issue><fpage>82</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-1969-6</pub-id><pub-id pub-id-type="pmid">32025007</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Aaltonen, L. A. et al. Pan-cancer analysis of whole genomes. <italic>Nature</italic><bold>578</bold>(7793), 82&#x02013;93 (2020).<pub-id pub-id-type="pmid">32025007</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Banck</surname><given-names>MS</given-names></name><name><surname>Kanwar</surname><given-names>R</given-names></name><name><surname>Kulkarni</surname><given-names>AA</given-names></name><name><surname>Boora</surname><given-names>GK</given-names></name><name><surname>Metge</surname><given-names>F</given-names></name><name><surname>Kipp</surname><given-names>BR</given-names></name><etal/></person-group><article-title>The genomic landscape of small intestine neuroendocrine tumors</article-title><source>J. Clin. Investig.</source><year>2013</year><volume>123</volume><issue>6</issue><fpage>2502</fpage><lpage>2508</lpage><pub-id pub-id-type="doi">10.1172/JCI67963</pub-id><pub-id pub-id-type="pmid">23676460</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Banck, M. S. et al. The genomic landscape of small intestine neuroendocrine tumors. <italic>J. Clin. Investig.</italic><bold>123</bold>(6), 2502&#x02013;2508 (2013).<pub-id pub-id-type="pmid">23676460</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>JM</given-names></name><name><surname>Kiezun</surname><given-names>A</given-names></name><name><surname>Ramos</surname><given-names>AH</given-names></name><name><surname>Serra</surname><given-names>S</given-names></name><name><surname>Pedamallu</surname><given-names>CS</given-names></name><name><surname>Qian</surname><given-names>ZR</given-names></name><etal/></person-group><article-title>Somatic mutation of CDKN1B in small intestine neuroendocrine tumors</article-title><source>Nat. Genet.</source><year>2013</year><volume>45</volume><issue>12</issue><fpage>1483</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.1038/ng.2821</pub-id><pub-id pub-id-type="pmid">24185511</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Francis, J. M. et al. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. <italic>Nat. Genet.</italic><bold>45</bold>(12), 1483&#x02013;1486 (2013).<pub-id pub-id-type="pmid">24185511</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e4;kinen</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Kasai</surname><given-names>Y</given-names></name><name><surname>Perez</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>GE</given-names></name><etal/></person-group><article-title>Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors</article-title><source>Genome Med.</source><year>2022</year><volume>14</volume><issue>1</issue><fpage>82</fpage><pub-id pub-id-type="doi">10.1186/s13073-022-01083-1</pub-id><pub-id pub-id-type="pmid">35922826</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">M&#x000e4;kinen, N. et al. Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors. <italic>Genome Med.</italic><bold>14</bold>(1), 82 (2022).<pub-id pub-id-type="pmid">35922826</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Elias</surname><given-names>E</given-names></name><name><surname>Ardalan</surname><given-names>A</given-names></name><name><surname>Lindberg</surname><given-names>M</given-names></name><name><surname>Reinsbach</surname><given-names>SE</given-names></name><name><surname>Muth</surname><given-names>A</given-names></name><name><surname>Nilsson</surname><given-names>O</given-names></name><etal/></person-group><article-title>Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><issue>1</issue><fpage>6367</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-26581-5</pub-id><pub-id pub-id-type="pmid">34737276</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Elias, E. et al. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine. <italic>Nat. Commun.</italic><bold>12</bold>(1), 6367 (2021).<pub-id pub-id-type="pmid">34737276</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>van Riet</surname><given-names>J</given-names></name><name><surname>van de Werken</surname><given-names>HJG</given-names></name><name><surname>Cuppen</surname><given-names>E</given-names></name><name><surname>Eskens</surname><given-names>FALM</given-names></name><name><surname>Tesselaar</surname><given-names>M</given-names></name><name><surname>van Veenendaal</surname><given-names>LM</given-names></name><etal/></person-group><article-title>The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><issue>1</issue><fpage>4612</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-24812-3</pub-id><pub-id pub-id-type="pmid">34326338</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">van Riet, J. et al. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets. <italic>Nat. Commun.</italic><bold>12</bold>(1), 4612 (2021).<pub-id pub-id-type="pmid">34326338</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Crona</surname><given-names>J</given-names></name><name><surname>Gustavsson</surname><given-names>T</given-names></name><name><surname>Norl&#x000e9;n</surname><given-names>O</given-names></name><name><surname>Edfeldt</surname><given-names>K</given-names></name><name><surname>&#x000c5;kerstr&#x000f6;m</surname><given-names>T</given-names></name><name><surname>Westin</surname><given-names>G</given-names></name><etal/></person-group><article-title>Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors</article-title><source>Ann. Surg. Oncol.</source><year>2015</year><volume>22</volume><issue>Suppl 3</issue><fpage>S1428</fpage><lpage>S1435</lpage><pub-id pub-id-type="doi">10.1245/s10434-014-4351-9</pub-id><pub-id pub-id-type="pmid">25586243</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Crona, J. et al. Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors. <italic>Ann. Surg. Oncol.</italic><bold>22</bold>(Suppl 3), S1428&#x02013;S1435 (2015).<pub-id pub-id-type="pmid">25586243</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>JL</given-names></name><name><surname>D&#x000ed;az de St&#x000e5;hl</surname><given-names>T</given-names></name><name><surname>Sj&#x000f6;blom</surname><given-names>T</given-names></name><name><surname>Westin</surname><given-names>G</given-names></name><name><surname>Dumanski</surname><given-names>JP</given-names></name><name><surname>Janson</surname><given-names>ET</given-names></name></person-group><article-title>Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors</article-title><source>Genes, Chromosom. Cancer</source><year>2011</year><volume>50</volume><issue>2</issue><fpage>82</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1002/gcc.20834</pub-id><pub-id pub-id-type="pmid">21104784</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Cunningham, J. L. et al. Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors. <italic>Genes, Chromosom. Cancer</italic><bold>50</bold>(2), 82&#x02013;94 (2011).<pub-id pub-id-type="pmid">21104784</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Samsom</surname><given-names>KG</given-names></name><name><surname>Levy</surname><given-names>S</given-names></name><name><surname>van Veenendaal</surname><given-names>LM</given-names></name><name><surname>Roepman</surname><given-names>P</given-names></name><name><surname>Kodach</surname><given-names>LL</given-names></name><name><surname>Steeghs</surname><given-names>N</given-names></name><etal/></person-group><article-title>Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours</article-title><source>Histopathology</source><year>2021</year><volume>78</volume><issue>4</issue><fpage>556</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1111/his.14252</pub-id><pub-id pub-id-type="pmid">32931025</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Samsom, K. G. et al. Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours. <italic>Histopathology</italic><bold>78</bold>(4), 556&#x02013;566 (2021).<pub-id pub-id-type="pmid">32931025</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>M&#x000e4;kinen</surname><given-names>N</given-names></name><name><surname>Kasai</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>GE</given-names></name><name><surname>Diosdado</surname><given-names>B</given-names></name><name><surname>Nakakura</surname><given-names>E</given-names></name><etal/></person-group><article-title>Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors</article-title><source>Genes Chromosom. Cancer.</source><year>2020</year><volume>59</volume><issue>9</issue><fpage>535</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1002/gcc.22850</pub-id><pub-id pub-id-type="pmid">32291827</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Zhang, Z. et al. Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors. <italic>Genes Chromosom. Cancer.</italic><bold>59</bold>(9), 535&#x02013;539 (2020).<pub-id pub-id-type="pmid">32291827</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Nieser</surname><given-names>M</given-names></name><name><surname>Henopp</surname><given-names>T</given-names></name><name><surname>Brix</surname><given-names>J</given-names></name><name><surname>Sto&#x000df;</surname><given-names>L</given-names></name><name><surname>Sitek</surname><given-names>B</given-names></name><name><surname>Naboulsi</surname><given-names>W</given-names></name><etal/></person-group><article-title>Loss of chromosome 18 in neuroendocrine tumors of the small intestine: The enigma remains</article-title><source>Neuroendocrinology</source><year>2017</year><volume>104</volume><issue>3</issue><fpage>302</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1159/000446917</pub-id><pub-id pub-id-type="pmid">27222126</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Nieser, M. et al. Loss of chromosome 18 in neuroendocrine tumors of the small intestine: The enigma remains. <italic>Neuroendocrinology</italic><bold>104</bold>(3), 302&#x02013;312 (2017).<pub-id pub-id-type="pmid">27222126</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Scarpa</surname><given-names>A</given-names></name></person-group><article-title>The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours</article-title><source>Ann. Endocrinol.</source><year>2019</year><volume>80</volume><issue>3</issue><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.ando.2019.04.010</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Scarpa, A. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours. <italic>Ann. Endocrinol.</italic><bold>80</bold>(3), 153&#x02013;158 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Priestley</surname><given-names>P</given-names></name><name><surname>Baber</surname><given-names>J</given-names></name><name><surname>Lolkema</surname><given-names>MP</given-names></name><name><surname>Steeghs</surname><given-names>N</given-names></name><name><surname>de Bruijn</surname><given-names>E</given-names></name><name><surname>Shale</surname><given-names>C</given-names></name><etal/></person-group><article-title>Pan-cancer whole-genome analyses of metastatic solid tumours</article-title><source>Nature</source><year>2019</year><volume>575</volume><issue>7781</issue><fpage>210</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1689-y</pub-id><pub-id pub-id-type="pmid">31645765</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. <italic>Nature</italic><bold>575</bold>(7781), 210&#x02013;216 (2019).<pub-id pub-id-type="pmid">31645765</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Alrezk</surname><given-names>R</given-names></name><name><surname>Hannah-Shmouni</surname><given-names>F</given-names></name><name><surname>Stratakis</surname><given-names>CA</given-names></name></person-group><article-title>MEN4 and CDKN1B mutations: The latest of the MEN syndromes</article-title><source>Endocr. Relat. Cancer</source><year>2017</year><volume>24</volume><issue>10</issue><fpage>T195</fpage><lpage>T208</lpage><pub-id pub-id-type="doi">10.1530/ERC-17-0243</pub-id><pub-id pub-id-type="pmid">28824003</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Alrezk, R., Hannah-Shmouni, F. &#x00026; Stratakis, C. A. MEN4 and CDKN1B mutations: The latest of the MEN syndromes. <italic>Endocr. Relat. Cancer</italic><bold>24</bold>(10), T195&#x02013;T208 (2017).<pub-id pub-id-type="pmid">28824003</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>E</given-names></name><name><surname>Arvidsson</surname><given-names>Y</given-names></name><name><surname>Sw&#x000e4;rd</surname><given-names>C</given-names></name><name><surname>Hofving</surname><given-names>T</given-names></name><name><surname>W&#x000e4;ngberg</surname><given-names>B</given-names></name><name><surname>Kristiansson</surname><given-names>E</given-names></name><etal/></person-group><article-title>Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets</article-title><source>Mod. Pathol.</source><year>2016</year><volume>29</volume><issue>6</issue><fpage>616</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1038/modpathol.2016.48</pub-id><pub-id pub-id-type="pmid">26965582</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Andersson, E. et al. Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets. <italic>Mod. Pathol.</italic><bold>29</bold>(6), 616&#x02013;629 (2016).<pub-id pub-id-type="pmid">26965582</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Mattiolo</surname><given-names>P</given-names></name><name><surname>Gkountakos</surname><given-names>A</given-names></name><name><surname>Centonze</surname><given-names>G</given-names></name><name><surname>Bevere</surname><given-names>M</given-names></name><name><surname>Piccoli</surname><given-names>P</given-names></name><name><surname>Ammendola</surname><given-names>S</given-names></name><etal/></person-group><article-title>Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups</article-title><source>Pathol. Res. Pract.</source><year>2023</year><volume>248</volume><fpage>154674</fpage><pub-id pub-id-type="doi">10.1016/j.prp.2023.154674</pub-id><pub-id pub-id-type="pmid">37454491</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Mattiolo, P. et al. Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups. <italic>Pathol. Res. Pract.</italic><bold>248</bold>, 154674 (2023).<pub-id pub-id-type="pmid">37454491</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name></person-group><article-title>Expression profiling of small intestinal neuroendocrine tumors identified pathways and gene networks linked to tumorigenesis and metastasis</article-title><source>Biosci. Rep.</source><year>2020</year><volume>40</volume><issue>6</issue><fpage>BSR20193860</fpage><pub-id pub-id-type="doi">10.1042/BSR20193860</pub-id><pub-id pub-id-type="pmid">32496505</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Wang, Q. &#x00026; Yu, C. Expression profiling of small intestinal neuroendocrine tumors identified pathways and gene networks linked to tumorigenesis and metastasis. <italic>Biosci. Rep.</italic><bold>40</bold>(6), BSR20193860 (2020).<pub-id pub-id-type="pmid">32496505</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Postel</surname><given-names>M</given-names></name><name><surname>Darabi</surname><given-names>S</given-names></name><name><surname>Howe</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Craig</surname><given-names>D</given-names></name><name><surname>Demeure</surname><given-names>M</given-names></name></person-group><article-title>Multiomic sequencing of paired primary and metastatic small bowel carcinoids [version 2; peer review: 2 approved]</article-title><source>F1000Research</source><year>2023</year><volume>12</volume><fpage>417</fpage><pub-id pub-id-type="doi">10.12688/f1000research.130251.2</pub-id><pub-id pub-id-type="pmid">37954063</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Postel, M. et al. Multiomic sequencing of paired primary and metastatic small bowel carcinoids [version 2; peer review: 2 approved]. <italic>F1000Research</italic><bold>12</bold>, 417 (2023).<pub-id pub-id-type="pmid">37954063</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>MJ</given-names></name><name><surname>Subramaniam</surname><given-names>PS</given-names></name><name><surname>Tang</surname><given-names>LH</given-names></name><name><surname>Grunn</surname><given-names>A</given-names></name><name><surname>Aburi</surname><given-names>M</given-names></name><name><surname>Rieckhof</surname><given-names>G</given-names></name><etal/></person-group><article-title>A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors</article-title><source>Nat. Genet.</source><year>2018</year><volume>50</volume><issue>7</issue><fpage>979</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0138-4</pub-id><pub-id pub-id-type="pmid">29915428</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Alvarez, M. J. et al. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. <italic>Nat. Genet.</italic><bold>50</bold>(7), 979&#x02013;989 (2018).<pub-id pub-id-type="pmid">29915428</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Meng</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Liao</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Potential effective diagnostic biomarker in patients with primary and metastatic small intestinal neuroendocrine tumors</article-title><source>Front. Genet.</source><year>2023</year><volume>14</volume><fpage>1110396</fpage><pub-id pub-id-type="doi">10.3389/fgene.2023.1110396</pub-id><pub-id pub-id-type="pmid">37091799</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Chen, J. et al. Potential effective diagnostic biomarker in patients with primary and metastatic small intestinal neuroendocrine tumors. <italic>Front. Genet.</italic><bold>14</bold>, 1110396 (2023).<pub-id pub-id-type="pmid">37091799</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Alexandrov</surname><given-names>LB</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Haradhvala</surname><given-names>NJ</given-names></name><name><surname>Huang</surname><given-names>MN</given-names></name><name><surname>Tian Ng</surname><given-names>AW</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The repertoire of mutational signatures in human cancer</article-title><source>Nature</source><year>2020</year><volume>578</volume><issue>7793</issue><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-1943-3</pub-id><pub-id pub-id-type="pmid">32025018</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. <italic>Nature</italic><bold>578</bold>(7793), 94&#x02013;101 (2020).<pub-id pub-id-type="pmid">32025018</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Steele</surname><given-names>CD</given-names></name><name><surname>Abbasi</surname><given-names>A</given-names></name><name><surname>Islam</surname><given-names>SMA</given-names></name><name><surname>Bowes</surname><given-names>AL</given-names></name><name><surname>Khandekar</surname><given-names>A</given-names></name><name><surname>Haase</surname><given-names>K</given-names></name><etal/></person-group><article-title>Signatures of copy number alterations in human cancer</article-title><source>Nature</source><year>2022</year><volume>606</volume><issue>7916</issue><fpage>984</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04738-6</pub-id><pub-id pub-id-type="pmid">35705804</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Steele, C. D. et al. Signatures of copy number alterations in human cancer. <italic>Nature</italic><bold>606</bold>(7916), 984&#x02013;991 (2022).<pub-id pub-id-type="pmid">35705804</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>J</given-names></name><name><surname>Fotouhi</surname><given-names>O</given-names></name><name><surname>Sulaiman</surname><given-names>L</given-names></name><name><surname>Kjellman</surname><given-names>M</given-names></name><name><surname>H&#x000f6;&#x000f6;g</surname><given-names>A</given-names></name><name><surname>Zedenius</surname><given-names>J</given-names></name><etal/></person-group><article-title>Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization</article-title><source>BMC Cancer</source><year>2013</year><volume>13</volume><issue>1</issue><fpage>505</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-13-505</pub-id><pub-id pub-id-type="pmid">24165089</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Hashemi, J. et al. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization. <italic>BMC Cancer</italic><bold>13</bold>(1), 505 (2013).<pub-id pub-id-type="pmid">24165089</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>IH</given-names></name><name><surname>Sohn</surname><given-names>M</given-names></name><name><surname>Lim</surname><given-names>HJ</given-names></name><name><surname>Yoon</surname><given-names>S</given-names></name><name><surname>Oh</surname><given-names>H</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name><etal/></person-group><article-title>Ahnak functions as a tumor suppressor via modulation of TGF&#x003b2;/Smad signaling pathway</article-title><source>Oncogene</source><year>2014</year><volume>33</volume><issue>38</issue><fpage>4675</fpage><lpage>4684</lpage><pub-id pub-id-type="doi">10.1038/onc.2014.69</pub-id><pub-id pub-id-type="pmid">24662814</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Lee, I. H. et al. Ahnak functions as a tumor suppressor via modulation of TGF&#x003b2;/Smad signaling pathway. <italic>Oncogene</italic><bold>33</bold>(38), 4675&#x02013;4684 (2014).<pub-id pub-id-type="pmid">24662814</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Nakajima-Takagi</surname><given-names>Y</given-names></name><name><surname>Aoyama</surname><given-names>K</given-names></name><name><surname>Tara</surname><given-names>S</given-names></name><name><surname>Oshima</surname><given-names>M</given-names></name><name><surname>Saraya</surname><given-names>A</given-names></name><etal/></person-group><article-title>Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies</article-title><source>J. Exp. Med.</source><year>2017</year><volume>214</volume><issue>10</issue><fpage>2901</fpage><lpage>2913</lpage><pub-id pub-id-type="doi">10.1084/jem.20170167</pub-id><pub-id pub-id-type="pmid">28827447</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Tanaka, T. et al. Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies. <italic>J. Exp. Med.</italic><bold>214</bold>(10), 2901&#x02013;2913 (2017).<pub-id pub-id-type="pmid">28827447</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Lefebure</surname><given-names>M</given-names></name><name><surname>Tothill</surname><given-names>RW</given-names></name><name><surname>Kruse</surname><given-names>E</given-names></name><name><surname>Hawkins</surname><given-names>ED</given-names></name><name><surname>Shortt</surname><given-names>J</given-names></name><name><surname>Matthews</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Genomic characterisation of E&#x003bc;-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><issue>1</issue><fpage>14581</fpage><pub-id pub-id-type="doi">10.1038/ncomms14581</pub-id><pub-id pub-id-type="pmid">28262675</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Lefebure, M. et al. Genomic characterisation of E&#x003bc;-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene. <italic>Nat. Commun.</italic><bold>8</bold>(1), 14581 (2017).<pub-id pub-id-type="pmid">28262675</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types</article-title><source>Cell Res.</source><year>2018</year><volume>28</volume><issue>5</issue><fpage>601</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1038/s41422-018-0019-5</pub-id><pub-id pub-id-type="pmid">29507395</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Cao, Y. et al. Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types. <italic>Cell Res.</italic><bold>28</bold>(5), 601&#x02013;604 (2018).<pub-id pub-id-type="pmid">29507395</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Garg</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Capdevila</surname><given-names>J</given-names></name><name><surname>Engstrom</surname><given-names>P</given-names></name><name><surname>Pommier</surname><given-names>R</given-names></name><etal/></person-group><article-title>Genomic profiling of NETs: A comprehensive analysis of the RADIANT trials</article-title><source>Endocr. Relat. Cancer</source><year>2019</year><volume>26</volume><issue>4</issue><fpage>391</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1530/ERC-18-0332</pub-id><pub-id pub-id-type="pmid">30667365</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Yao, J. et al. Genomic profiling of NETs: A comprehensive analysis of the RADIANT trials. <italic>Endocr. Relat. Cancer</italic><bold>26</bold>(4), 391&#x02013;403 (2019).<pub-id pub-id-type="pmid">30667365</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Ishaque</surname><given-names>N</given-names></name><name><surname>Abba</surname><given-names>ML</given-names></name><name><surname>Hauser</surname><given-names>C</given-names></name><name><surname>Patil</surname><given-names>N</given-names></name><name><surname>Paramasivam</surname><given-names>N</given-names></name><name><surname>Huebschmann</surname><given-names>D</given-names></name><etal/></person-group><article-title>Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><issue>1</issue><fpage>4782</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-07041-z</pub-id><pub-id pub-id-type="pmid">30429477</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Ishaque, N. et al. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer. <italic>Nat. Commun.</italic><bold>9</bold>(1), 4782 (2018).<pub-id pub-id-type="pmid">30429477</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Contractor</surname><given-names>T</given-names></name><name><surname>Clausen</surname><given-names>R</given-names></name><name><surname>Harris</surname><given-names>GR</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><name><surname>Carpizo</surname><given-names>DR</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><etal/></person-group><article-title>IGF2 drives formation of ileal neuroendocrine tumors in patients and mice</article-title><source>Endocr. Relat. Cancer</source><year>2020</year><volume>27</volume><issue>3</issue><fpage>175</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1530/ERC-19-0505</pub-id><pub-id pub-id-type="pmid">31951591</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Contractor, T. et al. IGF2 drives formation of ileal neuroendocrine tumors in patients and mice. <italic>Endocr. Relat. Cancer</italic><bold>27</bold>(3), 175&#x02013;186 (2020).<pub-id pub-id-type="pmid">31951591</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Dziuba&#x00144;ska-Kusibab</surname><given-names>PJ</given-names></name><name><surname>Berger</surname><given-names>H</given-names></name><name><surname>Battistini</surname><given-names>F</given-names></name><name><surname>Bouwman</surname><given-names>BAM</given-names></name><name><surname>Iftekhar</surname><given-names>A</given-names></name><name><surname>Katainen</surname><given-names>R</given-names></name><etal/></person-group><article-title>Colibactin DNA-damage signature indicates mutational impact in colorectal cancer</article-title><source>Nat. Med.</source><year>2020</year><volume>26</volume><issue>7</issue><fpage>1063</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0908-2</pub-id><pub-id pub-id-type="pmid">32483361</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Dziuba&#x00144;ska-Kusibab, P. J. et al. Colibactin DNA-damage signature indicates mutational impact in colorectal cancer. <italic>Nat. Med.</italic><bold>26</bold>(7), 1063&#x02013;1069 (2020).<pub-id pub-id-type="pmid">32483361</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Niraj</surname><given-names>J</given-names></name><name><surname>F&#x000e4;rkkil&#x000e4;</surname><given-names>A</given-names></name><name><surname>D&#x02019;Andrea</surname><given-names>AD</given-names></name></person-group><article-title>The Fanconi anemia pathway in cancer</article-title><source>Ann. Rev. Cancer Biol.</source><year>2019</year><volume>3</volume><issue>1</issue><fpage>457</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1146/annurev-cancerbio-030617-050422</pub-id><pub-id pub-id-type="pmid">30882047</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Niraj, J., F&#x000e4;rkkil&#x000e4;, A. &#x00026; D&#x02019;Andrea, A. D. The Fanconi anemia pathway in cancer. <italic>Ann. Rev. Cancer Biol.</italic><bold>3</bold>(1), 457&#x02013;478 (2019).<pub-id pub-id-type="pmid">30882047</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Heyer</surname><given-names>W-D</given-names></name></person-group><article-title>Homologous recombination in DNA repair and DNA damage tolerance</article-title><source>Cell Res.</source><year>2008</year><volume>18</volume><issue>1</issue><fpage>99</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/cr.2008.1</pub-id><pub-id pub-id-type="pmid">18166982</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Li, X. &#x00026; Heyer, W.-D. Homologous recombination in DNA repair and DNA damage tolerance. <italic>Cell Res.</italic><bold>18</bold>(1), 99&#x02013;113 (2008).<pub-id pub-id-type="pmid">18166982</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Walden</surname><given-names>H</given-names></name><name><surname>Deans</surname><given-names>AJ</given-names></name></person-group><article-title>The Fanconi anemia DNA repair pathway: Structural and functional insights into a complex disorder</article-title><source>Annu. Rev. Biophys.</source><year>2014</year><volume>43</volume><issue>1</issue><fpage>257</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1146/annurev-biophys-051013-022737</pub-id><pub-id pub-id-type="pmid">24773018</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Walden, H. &#x00026; Deans, A. J. The Fanconi anemia DNA repair pathway: Structural and functional insights into a complex disorder. <italic>Annu. Rev. Biophys.</italic><bold>43</bold>(1), 257&#x02013;278 (2014).<pub-id pub-id-type="pmid">24773018</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>K</given-names></name><name><surname>Kulke</surname><given-names>MH</given-names></name><name><surname>Chittenden</surname><given-names>A</given-names></name><name><surname>Ukaegbu</surname><given-names>C</given-names></name><name><surname>Astone</surname><given-names>K</given-names></name><name><surname>Alexander</surname><given-names>H</given-names></name><etal/></person-group><article-title>Clinical implications of pathogenic germline variants in small intestine neuroendocrine tumors (SI-NETs)</article-title><source>JCO Precis. Oncol.</source><year>2021</year><volume>5</volume><fpage>808</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1200/PO.21.00047</pub-id><pub-id pub-id-type="pmid">34994613</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Perez, K. et al. Clinical implications of pathogenic germline variants in small intestine neuroendocrine tumors (SI-NETs). <italic>JCO Precis. Oncol.</italic><bold>5</bold>, 808&#x02013;816 (2021).<pub-id pub-id-type="pmid">34994613</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Dumanski</surname><given-names>JP</given-names></name><name><surname>Rasi</surname><given-names>C</given-names></name><name><surname>Bj&#x000f6;rklund</surname><given-names>P</given-names></name><name><surname>Davies</surname><given-names>H</given-names></name><name><surname>Ali</surname><given-names>AS</given-names></name><name><surname>Gr&#x000f6;nberg</surname><given-names>M</given-names></name><etal/></person-group><article-title>A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors</article-title><source>Endocr. Relat. Cancer</source><year>2017</year><volume>24</volume><issue>8</issue><fpage>427</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1530/ERC-17-0196</pub-id><pub-id pub-id-type="pmid">28634180</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Dumanski, J. P. et al. A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors. <italic>Endocr. Relat. Cancer</italic><bold>24</bold>(8), 427&#x02013;443 (2017).<pub-id pub-id-type="pmid">28634180</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Curia</surname><given-names>MC</given-names></name><name><surname>Catalano</surname><given-names>T</given-names></name><name><surname>Aceto</surname><given-names>GM</given-names></name></person-group><article-title>MUTYH: Not just polyposis</article-title><source>World J. Clin. Oncol.</source><year>2020</year><volume>11</volume><issue>7</issue><fpage>428</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.5306/wjco.v11.i7.428</pub-id><pub-id pub-id-type="pmid">32821650</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Curia, M. C., Catalano, T. &#x00026; Aceto, G. M. MUTYH: Not just polyposis. <italic>World J. Clin. Oncol.</italic><bold>11</bold>(7), 428&#x02013;449 (2020).<pub-id pub-id-type="pmid">32821650</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Meindl</surname><given-names>A</given-names></name><name><surname>Hellebrand</surname><given-names>H</given-names></name><name><surname>Wiek</surname><given-names>C</given-names></name><name><surname>Erven</surname><given-names>V</given-names></name><name><surname>Wappenschmidt</surname><given-names>B</given-names></name><name><surname>Niederacher</surname><given-names>D</given-names></name><etal/></person-group><article-title>Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene</article-title><source>Nat. Genet.</source><year>2010</year><volume>42</volume><issue>5</issue><fpage>410</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1038/ng.569</pub-id><pub-id pub-id-type="pmid">20400964</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Meindl, A. et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. <italic>Nat. Genet.</italic><bold>42</bold>(5), 410&#x02013;414 (2010).<pub-id pub-id-type="pmid">20400964</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Manthei</surname><given-names>KA</given-names></name><name><surname>Keck</surname><given-names>JL</given-names></name></person-group><article-title>The BLM dissolvasome in DNA replication and repair</article-title><source>Cell. Mol. Life Sci.</source><year>2013</year><volume>70</volume><issue>21</issue><fpage>4067</fpage><lpage>4084</lpage><pub-id pub-id-type="doi">10.1007/s00018-013-1325-1</pub-id><pub-id pub-id-type="pmid">23543275</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Manthei, K. A. &#x00026; Keck, J. L. The BLM dissolvasome in DNA replication and repair. <italic>Cell. Mol. Life Sci.</italic><bold>70</bold>(21), 4067&#x02013;4084 (2013).<pub-id pub-id-type="pmid">23543275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>M</given-names></name><name><surname>Hansen</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>TGK</given-names></name><name><surname>Perearnau</surname><given-names>A</given-names></name><name><surname>Olsen</surname><given-names>AK</given-names></name><name><surname>Bram</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Genome-wide analysis of CDX2 binding in intestinal epithelial cells (Caco-2)*</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><issue>33</issue><fpage>25115</fpage><lpage>25125</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.089516</pub-id><pub-id pub-id-type="pmid">20551321</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Boyd, M. et al. Genome-wide analysis of CDX2 binding in intestinal epithelial cells (Caco-2)*. <italic>J. Biol. Chem.</italic><bold>285</bold>(33), 25115&#x02013;25125 (2010).<pub-id pub-id-type="pmid">20551321</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>R</given-names></name><name><surname>Kazenwadel</surname><given-names>J</given-names></name></person-group><article-title>Homeobox gene expression in the intestinal epithelium of adult mice</article-title><source>J. Biol. Chem.</source><year>1991</year><volume>266</volume><issue>5</issue><fpage>3246</fpage><lpage>3251</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)49981-4</pub-id><pub-id pub-id-type="pmid">1671571</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">James, R. &#x00026; Kazenwadel, J. Homeobox gene expression in the intestinal epithelium of adult mice. <italic>J. Biol. Chem.</italic><bold>266</bold>(5), 3246&#x02013;3251 (1991).<pub-id pub-id-type="pmid">1671571</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Mahamdallie</surname><given-names>SS</given-names></name><name><surname>Hanks</surname><given-names>S</given-names></name><name><surname>Karlin</surname><given-names>KL</given-names></name><name><surname>Zachariou</surname><given-names>A</given-names></name><name><surname>Perdeaux</surname><given-names>R</given-names></name><name><surname>Ruark</surname><given-names>E</given-names></name><etal/></person-group><article-title>Mutations in the transcriptional repressor REST predispose to Wilms tumor</article-title><source>Nat. Genet.</source><year>2015</year><volume>47</volume><issue>12</issue><fpage>1471</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1038/ng.3440</pub-id><pub-id pub-id-type="pmid">26551668</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Mahamdallie, S. S. et al. Mutations in the transcriptional repressor REST predispose to Wilms tumor. <italic>Nat. Genet.</italic><bold>47</bold>(12), 1471&#x02013;1474 (2015).<pub-id pub-id-type="pmid">26551668</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Karlin Kristen</surname><given-names>L</given-names></name><name><surname>Mondal</surname><given-names>G</given-names></name><name><surname>Hartman Jessica</surname><given-names>K</given-names></name><name><surname>Tyagi</surname><given-names>S</given-names></name><name><surname>Kurley Sarah</surname><given-names>J</given-names></name><name><surname>Bland Chris</surname><given-names>S</given-names></name><etal/></person-group><article-title>The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor</article-title><source>Cell Rep.</source><year>2014</year><volume>9</volume><issue>4</issue><fpage>1318</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.10.011</pub-id><pub-id pub-id-type="pmid">25453754</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Karlin Kristen, L. et al. The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor. <italic>Cell Rep.</italic><bold>9</bold>(4), 1318&#x02013;1332 (2014).<pub-id pub-id-type="pmid">25453754</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Kreisler</surname><given-names>A</given-names></name><name><surname>Strissel</surname><given-names>PL</given-names></name><name><surname>Strick</surname><given-names>R</given-names></name><name><surname>Neumann</surname><given-names>SB</given-names></name><name><surname>Schumacher</surname><given-names>U</given-names></name><name><surname>Becker</surname><given-names>CM</given-names></name></person-group><article-title>Regulation of the NRSF/REST gene by methylation and CREB affects the cellular phenotype of small-cell lung cancer</article-title><source>Oncogene</source><year>2010</year><volume>29</volume><issue>43</issue><fpage>5828</fpage><lpage>5838</lpage><pub-id pub-id-type="doi">10.1038/onc.2010.321</pub-id><pub-id pub-id-type="pmid">20697351</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Kreisler, A. et al. Regulation of the NRSF/REST gene by methylation and CREB affects the cellular phenotype of small-cell lung cancer. <italic>Oncogene</italic><bold>29</bold>(43), 5828&#x02013;5838 (2010).<pub-id pub-id-type="pmid">20697351</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Oberndorfer</surname><given-names>S</given-names></name></person-group><article-title>Karzinoide tumoren des dunndarms</article-title><source>Frankf Zschr Path.</source><year>1907</year><volume>1</volume><fpage>426</fpage></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Oberndorfer, S. Karzinoide tumoren des dunndarms. <italic>Frankf Zschr Path.</italic><bold>1</bold>, 426 (1907).</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Gosset</surname><given-names>A</given-names></name></person-group><article-title>Tumeurs endocrines de l&#x02019;appendice</article-title><source>Press Med.</source><year>1914</year><volume>22</volume><fpage>37</fpage><lpage>40</lpage></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Gosset, A. Tumeurs endocrines de l&#x02019;appendice. <italic>Press Med.</italic><bold>22</bold>, 37&#x02013;40 (1914).</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>SE</given-names></name><name><surname>Dowrey</surname><given-names>TW</given-names></name><name><surname>Villacorta Martin</surname><given-names>C</given-names></name><name><surname>Bi</surname><given-names>K</given-names></name><name><surname>Titchen</surname><given-names>B</given-names></name><name><surname>Johri</surname><given-names>S</given-names></name><etal/></person-group><article-title>Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors</article-title><source>Sci. Adv.</source><year>2023</year><volume>9</volume><issue>39</issue><fpage>eadd9668</fpage><pub-id pub-id-type="doi">10.1126/sciadv.add9668</pub-id><pub-id pub-id-type="pmid">37756410</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Hoffman, S. E. et al. Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors. <italic>Sci. Adv.</italic><bold>9</bold>(39), eadd9668 (2023).<pub-id pub-id-type="pmid">37756410</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Elmentaite</surname><given-names>R</given-names></name><name><surname>Kumasaka</surname><given-names>N</given-names></name><name><surname>Roberts</surname><given-names>K</given-names></name><name><surname>Fleming</surname><given-names>A</given-names></name><name><surname>Dann</surname><given-names>E</given-names></name><name><surname>King</surname><given-names>HW</given-names></name><etal/></person-group><article-title>Cells of the human intestinal tract mapped across space and time</article-title><source>Nature</source><year>2021</year><volume>597</volume><issue>7875</issue><fpage>250</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03852-1</pub-id><pub-id pub-id-type="pmid">34497389</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Elmentaite, R. et al. Cells of the human intestinal tract mapped across space and time. <italic>Nature</italic><bold>597</bold>(7875), 250&#x02013;255 (2021).<pub-id pub-id-type="pmid">34497389</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Beumer</surname><given-names>J</given-names></name><name><surname>Artegiani</surname><given-names>B</given-names></name><name><surname>Post</surname><given-names>Y</given-names></name><name><surname>Reimann</surname><given-names>F</given-names></name><name><surname>Gribble</surname><given-names>F</given-names></name><name><surname>Nguyen</surname><given-names>TN</given-names></name><etal/></person-group><article-title>Enteroendocrine cells switch hormone expression along the crypt-to-villus BMP signalling gradient</article-title><source>Nat. Cell Biol.</source><year>2018</year><volume>20</volume><issue>8</issue><fpage>909</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1038/s41556-018-0143-y</pub-id><pub-id pub-id-type="pmid">30038251</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Beumer, J. et al. Enteroendocrine cells switch hormone expression along the crypt-to-villus BMP signalling gradient. <italic>Nat. Cell Biol.</italic><bold>20</bold>(8), 909&#x02013;916 (2018).<pub-id pub-id-type="pmid">30038251</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Edfeldt</surname><given-names>K</given-names></name><name><surname>Ahmad</surname><given-names>T</given-names></name><name><surname>&#x000c5;kerstr&#x000f6;m</surname><given-names>G</given-names></name><name><surname>Janson</surname><given-names>ET</given-names></name><name><surname>Hellman</surname><given-names>P</given-names></name><name><surname>St&#x000e5;lberg</surname><given-names>P</given-names></name><etal/></person-group><article-title>TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors</article-title><source>Endocr. Relat. Cancer</source><year>2014</year><volume>21</volume><issue>2</issue><fpage>275</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1530/ERC-13-0419</pub-id><pub-id pub-id-type="pmid">24351681</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Edfeldt, K. et al. TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors. <italic>Endocr. Relat. Cancer</italic><bold>21</bold>(2), 275&#x02013;284 (2014).<pub-id pub-id-type="pmid">24351681</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Hofving</surname><given-names>T</given-names></name><name><surname>Elias</surname><given-names>E</given-names></name><name><surname>Rehammar</surname><given-names>A</given-names></name><name><surname>Inge</surname><given-names>L</given-names></name><name><surname>Altiparmak</surname><given-names>G</given-names></name><name><surname>Persson</surname><given-names>M</given-names></name><etal/></person-group><article-title>SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors</article-title><source>BMC Cancer</source><year>2021</year><volume>21</volume><issue>1</issue><fpage>101</fpage><pub-id pub-id-type="doi">10.1186/s12885-021-07786-9</pub-id><pub-id pub-id-type="pmid">33509126</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Hofving, T. et al. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors. <italic>BMC Cancer</italic><bold>21</bold>(1), 101 (2021).<pub-id pub-id-type="pmid">33509126</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Contractor</surname><given-names>T</given-names></name><name><surname>Harris</surname><given-names>CR</given-names></name></person-group><article-title>Loss of copy of MIR1-2 increases CDK4 expression in ileal neuroendocrine tumors</article-title><source>Oncogenesis</source><year>2020</year><volume>9</volume><issue>3</issue><fpage>37</fpage><pub-id pub-id-type="doi">10.1038/s41389-020-0221-4</pub-id><pub-id pub-id-type="pmid">32198354</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Contractor, T. &#x00026; Harris, C. R. Loss of copy of MIR1-2 increases CDK4 expression in ileal neuroendocrine tumors. <italic>Oncogenesis</italic><bold>9</bold>(3), 37 (2020).<pub-id pub-id-type="pmid">32198354</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Merola</surname><given-names>E</given-names></name><name><surname>Perren</surname><given-names>A</given-names></name><name><surname>Rinke</surname><given-names>A</given-names></name><name><surname>Zerbi</surname><given-names>A</given-names></name><name><surname>McNamara</surname><given-names>MG</given-names></name><name><surname>Arsenic</surname><given-names>R</given-names></name><etal/></person-group><article-title>High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intent</article-title><source>J. Neuroendocrinol.</source><year>2022</year><volume>34</volume><issue>10</issue><fpage>e13193</fpage><pub-id pub-id-type="doi">10.1111/jne.13193</pub-id><pub-id pub-id-type="pmid">36306194</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Merola, E. et al. High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intent. <italic>J. Neuroendocrinol.</italic><bold>34</bold>(10), e13193 (2022).<pub-id pub-id-type="pmid">36306194</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Westbrook</surname><given-names>TF</given-names></name><name><surname>Martin</surname><given-names>ES</given-names></name><name><surname>Schlabach</surname><given-names>MR</given-names></name><name><surname>Leng</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>AC</given-names></name><name><surname>Feng</surname><given-names>B</given-names></name><etal/></person-group><article-title>A genetic screen for candidate tumor suppressors identifies REST</article-title><source>Cell</source><year>2005</year><volume>121</volume><issue>6</issue><fpage>837</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.03.033</pub-id><pub-id pub-id-type="pmid">15960972</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Westbrook, T. F. et al. A genetic screen for candidate tumor suppressors identifies REST. <italic>Cell</italic><bold>121</bold>(6), 837&#x02013;848 (2005).<pub-id pub-id-type="pmid">15960972</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y-T</given-names></name><name><surname>Lin</surname><given-names>T-P</given-names></name><name><surname>Campbell</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>C-C</given-names></name><name><surname>Lee</surname><given-names>S-H</given-names></name><name><surname>Lee</surname><given-names>H-C</given-names></name><etal/></person-group><article-title>REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>42795</fpage><pub-id pub-id-type="doi">10.1038/srep42795</pub-id><pub-id pub-id-type="pmid">28256535</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Chang, Y.-T. et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. <italic>Sci. Rep.</italic><bold>7</bold>(1), 42795 (2017).<pub-id pub-id-type="pmid">28256535</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Shue</surname><given-names>YT</given-names></name><name><surname>Drainas</surname><given-names>AP</given-names></name><name><surname>Li</surname><given-names>NY</given-names></name><name><surname>Pearsall</surname><given-names>SM</given-names></name><name><surname>Morgan</surname><given-names>D</given-names></name><name><surname>Sinnott-Armstrong</surname><given-names>N</given-names></name><etal/></person-group><article-title>A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs</article-title><source>Nat. Commun.</source><year>2022</year><volume>13</volume><issue>1</issue><fpage>2690</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-30416-2</pub-id><pub-id pub-id-type="pmid">35577801</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Shue, Y. T. et al. A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs. <italic>Nat. Commun.</italic><bold>13</bold>(1), 2690 (2022).<pub-id pub-id-type="pmid">35577801</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name></person-group><article-title>Fast and accurate short read alignment with Burrows&#x02013;Wheeler transform</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><issue>14</issue><fpage>1754</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id><pub-id pub-id-type="pmid">19451168</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Li, H. &#x00026; Durbin, R. Fast and accurate short read alignment with Burrows&#x02013;Wheeler transform. <italic>Bioinformatics</italic><bold>25</bold>(14), 1754&#x02013;1760 (2009).<pub-id pub-id-type="pmid">19451168</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Handsaker</surname><given-names>B</given-names></name><name><surname>Wysoker</surname><given-names>A</given-names></name><name><surname>Fennell</surname><given-names>T</given-names></name><name><surname>Ruan</surname><given-names>J</given-names></name><name><surname>Homer</surname><given-names>N</given-names></name><etal/></person-group><article-title>The sequence alignment/map format and SAMtools</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><issue>16</issue><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><pub-id pub-id-type="pmid">19505943</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Li, H. et al. The sequence alignment/map format and SAMtools. <italic>Bioinformatics</italic><bold>25</bold>(16), 2078&#x02013;2079 (2009).<pub-id pub-id-type="pmid">19505943</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Tarasov</surname><given-names>A</given-names></name><name><surname>Vilella</surname><given-names>AJ</given-names></name><name><surname>Cuppen</surname><given-names>E</given-names></name><name><surname>Nijman</surname><given-names>IJ</given-names></name><name><surname>Prins</surname><given-names>P</given-names></name></person-group><article-title>Sambamba: Fast processing of NGS alignment formats</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><issue>12</issue><fpage>2032</fpage><lpage>2034</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv098</pub-id><pub-id pub-id-type="pmid">25697820</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. &#x00026; Prins, P. Sambamba: Fast processing of NGS alignment formats. <italic>Bioinformatics</italic><bold>31</bold>(12), 2032&#x02013;2034 (2015).<pub-id pub-id-type="pmid">25697820</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Bonfield</surname><given-names>JK</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Ohan</surname><given-names>V</given-names></name><name><surname>Whitwham</surname><given-names>A</given-names></name><etal/></person-group><article-title>HTSlib: C library for reading/writing high-throughput sequencing data</article-title><source>GigaScience</source><year>2021</year><volume>10</volume><issue>2</issue><fpage>giab007</fpage><pub-id pub-id-type="doi">10.1093/gigascience/giab007</pub-id><pub-id pub-id-type="pmid">33594436</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Bonfield, J. K. et al. HTSlib: C library for reading/writing high-throughput sequencing data. <italic>GigaScience</italic><bold>10</bold>(2), giab007 (2021).<pub-id pub-id-type="pmid">33594436</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Dunham</surname><given-names>I</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Aldred</surname><given-names>SF</given-names></name><name><surname>Collins</surname><given-names>PJ</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Doyle</surname><given-names>F</given-names></name><etal/></person-group><article-title>An integrated encyclopedia of DNA elements in the human genome</article-title><source>Nature</source><year>2012</year><volume>489</volume><issue>7414</issue><fpage>57</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature11247</pub-id><pub-id pub-id-type="pmid">22955616</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. <italic>Nature</italic><bold>489</bold>(7414), 57&#x02013;74 (2012).<pub-id pub-id-type="pmid">22955616</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Rimmer</surname><given-names>A</given-names></name><name><surname>Phan</surname><given-names>H</given-names></name><name><surname>Mathieson</surname><given-names>I</given-names></name><name><surname>Iqbal</surname><given-names>Z</given-names></name><name><surname>Twigg</surname><given-names>SRF</given-names></name><name><surname>Wilkie</surname><given-names>AOM</given-names></name><etal/></person-group><article-title>Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications</article-title><source>Nat. Genet.</source><year>2014</year><volume>46</volume><issue>8</issue><fpage>912</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1038/ng.3036</pub-id><pub-id pub-id-type="pmid">25017105</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Rimmer, A. et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. <italic>Nat. Genet.</italic><bold>46</bold>(8), 912&#x02013;918 (2014).<pub-id pub-id-type="pmid">25017105</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="other">Kleinheinz, K., Bludau, I., H&#x000fc;bschmann, D., Heinold, M., Kensche, P., Gu, Z. et al. ACEseq&#x02013;allele specific copy number estimation from whole genome sequencing. <italic>bioRxiv</italic>. 210807 (2017).</mixed-citation></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Mermel</surname><given-names>CH</given-names></name><name><surname>Schumacher</surname><given-names>SE</given-names></name><name><surname>Hill</surname><given-names>B</given-names></name><name><surname>Meyerson</surname><given-names>ML</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name></person-group><article-title>GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers</article-title><source>Genome Biol.</source><year>2011</year><volume>12</volume><issue>4</issue><fpage>R41</fpage><pub-id pub-id-type="doi">10.1186/gb-2011-12-4-r41</pub-id><pub-id pub-id-type="pmid">21527027</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. <italic>Genome Biol.</italic><bold>12</bold>(4), R41 (2011).<pub-id pub-id-type="pmid">21527027</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000fc;bschmann</surname><given-names>D</given-names></name><name><surname>Jopp-Saile</surname><given-names>L</given-names></name><name><surname>Andresen</surname><given-names>C</given-names></name><name><surname>Kr&#x000e4;mer</surname><given-names>S</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Heilig</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Analysis of mutational signatures with yet another package for signature analysis</article-title><source>Genes Chromosom. Cancer</source><year>2021</year><volume>60</volume><issue>5</issue><fpage>314</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1002/gcc.22918</pub-id><pub-id pub-id-type="pmid">33222322</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">H&#x000fc;bschmann, D. et al. Analysis of mutational signatures with yet another package for signature analysis. <italic>Genes Chromosom. Cancer</italic><bold>60</bold>(5), 314&#x02013;331 (2021).<pub-id pub-id-type="pmid">33222322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee-Six</surname><given-names>H</given-names></name><name><surname>Olafsson</surname><given-names>S</given-names></name><name><surname>Ellis</surname><given-names>P</given-names></name><name><surname>Osborne</surname><given-names>RJ</given-names></name><name><surname>Sanders</surname><given-names>MA</given-names></name><name><surname>Moore</surname><given-names>L</given-names></name><etal/></person-group><article-title>The landscape of somatic mutation in normal colorectal epithelial cells</article-title><source>Nature</source><year>2019</year><volume>574</volume><issue>7779</issue><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1672-7</pub-id><pub-id pub-id-type="pmid">31645730</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. <italic>Nature</italic><bold>574</bold>(7779), 532&#x02013;537 (2019).<pub-id pub-id-type="pmid">31645730</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Van Loo</surname><given-names>P</given-names></name><name><surname>Nordgard</surname><given-names>SH</given-names></name><name><surname>Lingj&#x000e6;rde</surname><given-names>OC</given-names></name><name><surname>Russnes</surname><given-names>HG</given-names></name><name><surname>Rye</surname><given-names>IH</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><etal/></person-group><article-title>Allele-specific copy number analysis of tumors</article-title><source>Proc. Natl. Acad. Sci.</source><year>2010</year><volume>107</volume><issue>39</issue><fpage>16910</fpage><lpage>16915</lpage><pub-id pub-id-type="doi">10.1073/pnas.1009843107</pub-id><pub-id pub-id-type="pmid">20837533</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Van Loo, P. et al. Allele-specific copy number analysis of tumors. <italic>Proc. Natl. Acad. Sci.</italic><bold>107</bold>(39), 16910&#x02013;16915 (2010).<pub-id pub-id-type="pmid">20837533</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstrom</surname><given-names>EN</given-names></name><name><surname>Huang</surname><given-names>MN</given-names></name><name><surname>Mahto</surname><given-names>U</given-names></name><name><surname>Barnes</surname><given-names>M</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Rozen</surname><given-names>SG</given-names></name><etal/></person-group><article-title>SigProfilerMatrixGenerator: A tool for visualizing and exploring patterns of small mutational events</article-title><source>BMC Genom.</source><year>2019</year><volume>20</volume><issue>1</issue><fpage>685</fpage><pub-id pub-id-type="doi">10.1186/s12864-019-6041-2</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Bergstrom, E. N. et al. SigProfilerMatrixGenerator: A tool for visualizing and exploring patterns of small mutational events. <italic>BMC Genom.</italic><bold>20</bold>(1), 685 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Gay</surname><given-names>M</given-names></name><name><surname>Vangara</surname><given-names>R</given-names></name><name><surname>Barnes</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Islam</surname><given-names>SMA</given-names></name><name><surname>Vermes</surname><given-names>I</given-names></name><etal/></person-group><article-title>Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment</article-title><source>Bioinformatics</source><year>2023</year><volume>39</volume><issue>12</issue><fpage>btad756</fpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btad756</pub-id><pub-id pub-id-type="pmid">38096571</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">D&#x000ed;az-Gay, M. et al. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. <italic>Bioinformatics</italic><bold>39</bold>(12), btad756 (2023).<pub-id pub-id-type="pmid">38096571</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Feuerbach</surname><given-names>L</given-names></name><name><surname>Sieverling</surname><given-names>L</given-names></name><name><surname>Deeg</surname><given-names>KI</given-names></name><name><surname>Ginsbach</surname><given-names>P</given-names></name><name><surname>Hutter</surname><given-names>B</given-names></name><name><surname>Buchhalter</surname><given-names>I</given-names></name><etal/></person-group><article-title>TelomereHunter&#x02013;in silico estimation of telomere content and composition from cancer genomes</article-title><source>BMC Bioinf.</source><year>2019</year><volume>20</volume><issue>1</issue><fpage>272</fpage><pub-id pub-id-type="doi">10.1186/s12859-019-2851-0</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Feuerbach, L. et al. TelomereHunter&#x02013;in silico estimation of telomere content and composition from cancer genomes. <italic>BMC Bioinf.</italic><bold>20</bold>(1), 272 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group><article-title>A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data</article-title><source>Bioinformatics</source><year>2011</year><volume>27</volume><issue>21</issue><fpage>2987</fpage><lpage>2993</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr509</pub-id><pub-id pub-id-type="pmid">21903627</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. <italic>Bioinformatics</italic><bold>27</bold>(21), 2987&#x02013;2993 (2011).<pub-id pub-id-type="pmid">21903627</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakken</surname><given-names>S</given-names></name><name><surname>Saveliev</surname><given-names>V</given-names></name><name><surname>Hofmann</surname><given-names>O</given-names></name><name><surname>M&#x000f8;ller</surname><given-names>P</given-names></name><name><surname>Myklebost</surname><given-names>O</given-names></name><name><surname>Hovig</surname><given-names>E</given-names></name></person-group><article-title>Cancer predisposition sequencing reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer</article-title><source>Int. J. Cancer</source><year>2021</year><volume>149</volume><issue>11</issue><fpage>1955</fpage><lpage>1960</lpage><pub-id pub-id-type="doi">10.1002/ijc.33749</pub-id><pub-id pub-id-type="pmid">34310709</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Nakken, S. et al. Cancer predisposition sequencing reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer. <italic>Int. J. Cancer</italic><bold>149</bold>(11), 1955&#x02013;1960 (2021).<pub-id pub-id-type="pmid">34310709</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>C</given-names></name><name><surname>Borges-Monroy</surname><given-names>R</given-names></name><name><surname>Viswanadham</surname><given-names>VV</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Comprehensive identification of transposable element insertions using multiple sequencing technologies</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><issue>1</issue><fpage>3836</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-24041-8</pub-id><pub-id pub-id-type="pmid">34158502</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Chu, C. et al. Comprehensive identification of transposable element insertions using multiple sequencing technologies. <italic>Nat. Commun.</italic><bold>12</bold>(1), 3836 (2021).<pub-id pub-id-type="pmid">34158502</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>DE</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Langmead</surname><given-names>B</given-names></name></person-group><article-title>Improved metagenomic analysis with Kraken 2</article-title><source>Genome Biol.</source><year>2019</year><volume>20</volume><issue>1</issue><fpage>257</fpage><pub-id pub-id-type="doi">10.1186/s13059-019-1891-0</pub-id><pub-id pub-id-type="pmid">31779668</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Wood, D. E., Lu, J. &#x00026; Langmead, B. Improved metagenomic analysis with Kraken 2. <italic>Genome Biol.</italic><bold>20</bold>(1), 257 (2019).<pub-id pub-id-type="pmid">31779668</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Breitwieser</surname><given-names>FP</given-names></name><name><surname>Thielen</surname><given-names>P</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>Bracken: Estimating species abundance in metagenomics data</article-title><source>PeerJ. Comput. Sci.</source><year>2017</year><volume>3</volume><fpage>e104</fpage><pub-id pub-id-type="doi">10.7717/peerj-cs.104</pub-id><pub-id pub-id-type="pmid">40271438</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Lu, J., Breitwieser, F. P., Thielen, P. &#x00026; Salzberg, S. L. Bracken: Estimating species abundance in metagenomics data. <italic>PeerJ. Comput. Sci.</italic><bold>3</bold>, e104 (2017).<pub-id pub-id-type="pmid">40271438</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>AR</given-names></name><name><surname>Hall</surname><given-names>IM</given-names></name></person-group><article-title>BEDTools: A flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><issue>6</issue><fpage>841</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><pub-id pub-id-type="pmid">20110278</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Quinlan, A. R. &#x00026; Hall, I. M. BEDTools: A flexible suite of utilities for comparing genomic features. <italic>Bioinformatics</italic><bold>26</bold>(6), 841&#x02013;842 (2010).<pub-id pub-id-type="pmid">20110278</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><etal/></person-group><article-title>STAR: Ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><year>2012</year><volume>29</volume><issue>1</issue><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. <italic>Bioinformatics</italic><bold>29</bold>(1), 15&#x02013;21 (2012).<pub-id pub-id-type="pmid">23104886</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>featureCounts: An efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><year>2013</year><volume>30</volume><issue>7</issue><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Liao, Y., Smyth, G. K. &#x00026; Shi, W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. <italic>Bioinformatics</italic><bold>30</bold>(7), 923&#x02013;930 (2013).<pub-id pub-id-type="pmid">24227677</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol.</source><year>2014</year><volume>15</volume><issue>12</issue><fpage>550</fpage><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Love, M. I., Huber, W. &#x00026; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. <italic>Genome Biol.</italic><bold>15</bold>(12), 550 (2014).<pub-id pub-id-type="pmid">25516281</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Pedregosa</surname><given-names>F</given-names></name><name><surname>Varoquaux</surname><given-names>G</given-names></name><name><surname>Gramfort</surname><given-names>A</given-names></name><name><surname>Miche</surname><given-names>V</given-names></name><name><surname>Thirion</surname><given-names>B</given-names></name><name><surname>Grisel</surname><given-names>O</given-names></name><name><surname>Blondel</surname><given-names>M</given-names></name><name><surname>Prettenhofer</surname><given-names>P</given-names></name><name><surname>Weiss</surname><given-names>R</given-names></name><name><surname>Dubourg</surname><given-names>V</given-names></name><name><surname>Vanderplas</surname><given-names>J</given-names></name><name><surname>Passos</surname><given-names>A</given-names></name><name><surname>Cournapeau</surname><given-names>D</given-names></name><name><surname>Brucher</surname><given-names>M</given-names></name><name><surname>Perrot</surname><given-names>M</given-names></name><name><surname>Duchesna</surname><given-names>E</given-names></name></person-group><article-title>Scikit-learn: Machine learning in Python</article-title><source>J. Mach. Learn. Res.</source><year>2011</year><volume>12</volume><fpage>2825</fpage><lpage>2830</lpage></element-citation><mixed-citation id="mc-CR81" publication-type="journal">Pedregosa, F. et al. Scikit-learn: Machine learning in Python. <italic>J. Mach. Learn. Res.</italic><bold>12</bold>, 2825&#x02013;2830 (2011).</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Hyv&#x000e4;rinen</surname><given-names>A</given-names></name><name><surname>Oja</surname><given-names>E</given-names></name></person-group><article-title>Independent component analysis: Algorithms and applications</article-title><source>Neural Netw.</source><year>2000</year><volume>13</volume><issue>4</issue><fpage>411</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/S0893-6080(00)00026-5</pub-id><pub-id pub-id-type="pmid">10946390</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Hyv&#x000e4;rinen, A. &#x00026; Oja, E. Independent component analysis: Algorithms and applications. <italic>Neural Netw.</italic><bold>13</bold>(4), 411&#x02013;430 (2000).<pub-id pub-id-type="pmid">10946390</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>Proc. Natl. Acad. Sci.</source><year>2005</year><volume>102</volume><issue>43</issue><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. <italic>Proc. Natl. Acad. Sci.</italic><bold>102</bold>(43), 15545&#x02013;15550 (2005).<pub-id pub-id-type="pmid">16199517</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Kuleshov</surname><given-names>MV</given-names></name><name><surname>Jones</surname><given-names>MR</given-names></name><name><surname>Rouillard</surname><given-names>AD</given-names></name><name><surname>Fernandez</surname><given-names>NF</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Enrichr: A comprehensive gene set enrichment analysis web server 2016 update</article-title><source>Nucleic Acids Res.</source><year>2016</year><volume>44</volume><issue>W1</issue><fpage>W90</fpage><lpage>W97</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id><pub-id pub-id-type="pmid">27141961</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Kuleshov, M. V. et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. <italic>Nucleic Acids Res.</italic><bold>44</bold>(W1), W90&#x02013;W97 (2016).<pub-id pub-id-type="pmid">27141961</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><etal/></person-group><article-title>clusterProfiler 4.0: A universal enrichment tool for interpreting omics data</article-title><source>Innovation</source><year>2021</year><volume>2</volume><issue>3</issue><fpage>100141</fpage><pub-id pub-id-type="pmid">34557778</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. <italic>Innovation</italic><bold>2</bold>(3), 100141 (2021).<pub-id pub-id-type="pmid">34557778</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>Q-Y</given-names></name></person-group><article-title>ReactomePA: An R/Bioconductor package for reactome pathway analysis and visualization</article-title><source>Mol. BioSyst.</source><year>2016</year><volume>12</volume><issue>2</issue><fpage>477</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1039/C5MB00663E</pub-id><pub-id pub-id-type="pmid">26661513</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Yu, G. &#x00026; He, Q.-Y. ReactomePA: An R/Bioconductor package for reactome pathway analysis and visualization. <italic>Mol. BioSyst.</italic><bold>12</bold>(2), 477&#x02013;479 (2016).<pub-id pub-id-type="pmid">26661513</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname><given-names>A</given-names></name><name><surname>Hanna</surname><given-names>M</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Sivachenko</surname><given-names>A</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Kernytsky</surname><given-names>A</given-names></name><etal/></person-group><article-title>The genome analysis toolkit: A mapreduce framework for analyzing next-generation DNA sequencing data</article-title><source>Genome Res.</source><year>2010</year><volume>20</volume><issue>9</issue><fpage>1297</fpage><lpage>1303</lpage><pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id><pub-id pub-id-type="pmid">20644199</pub-id>
</element-citation><mixed-citation id="mc-CR87" publication-type="journal">McKenna, A. et al. The genome analysis toolkit: A mapreduce framework for analyzing next-generation DNA sequencing data. <italic>Genome Res.</italic><bold>20</bold>(9), 1297&#x02013;1303 (2010).<pub-id pub-id-type="pmid">20644199</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>FA</given-names></name><name><surname>Angerer</surname><given-names>P</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><article-title>SCANPY: Large-scale single-cell gene expression data analysis</article-title><source>Genome Biol.</source><year>2018</year><volume>19</volume><issue>1</issue><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/s13059-017-1382-0</pub-id><pub-id pub-id-type="pmid">29409532</pub-id>
</element-citation><mixed-citation id="mc-CR88" publication-type="journal">Wolf, F. A., Angerer, P. &#x00026; Theis, F. J. SCANPY: Large-scale single-cell gene expression data analysis. <italic>Genome Biol.</italic><bold>19</bold>(1), 15 (2018).<pub-id pub-id-type="pmid">29409532</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>